ShiftPixy (PIXY) 10-K12 Dec 222022 FY Annual reportFinancial data

Company Profile

Cover

Cover - USD ($) $ in Thousands	12 Months Ended
Cover - USD ($) $ in Thousands	Aug. 31, 2022	Dec. 12, 2022	Feb. 28, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Aug. 31, 2022
Current Fiscal Year End Date	--08-31
Document Transition Report	false
Entity File Number	024-10557
Entity Registrant Name	SHIFTPIXY, INC.
Entity Incorporation, State or Country Code	WY
Entity Tax Identification Number	47-4211438
Entity Address, Address Line One	501 Brickell Key Drive
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33131
City Area Code	888
Local Phone Number	798-9100
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	PIXY
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 39,870
Entity Common Stock, Shares Outstanding		9,671,196
Entity Central Index Key	0001675634
Amendment Flag	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022

Audit Information

Audit Information	12 Months Ended
Audit Information	Aug. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	688
Auditor Name	Marcum LLP
Auditor Location	New York, NY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Current assets
Cash	$ 618	$ 1,199
Accounts receivable	279	498
Unbilled accounts receivable	2,105	2,741
Deposit – workers’ compensation	0	155
Prepaid expenses	696	605
Other current assets	187	126
Current assets of discontinued operations	0	356
Cash and marketable securities held in Trust Account (See Notes 2 and 5)	116,969	0
Total current assets	120,854	5,680
Fixed assets, net	2,769	2,784
ROU operating lease	4,076
Note receivable, net	0	4,004
Deposits – workers’ compensation	0	386
Deposits and other assets	919	944
Deferred offering costs – SPACs (See Note 5 and 6)	0	48,261
Non-current assets of discontinued operations	0	883
Total assets	128,618	62,942
Current liabilities
Accounts payable and other accrued liabilities	17,122	6,553
Payroll related liabilities	16,055	7,876
Accrued workers’ compensation costs	567	663
Current liabilities of discontinued operations	1,362	1,516
Class A common shares subject to possible redemption 11,500,000 and no shares at $10.15 per share redemption value as of August 31, 2022 and August 31, 2021 (See Notes 2 and 5)	116,969	0
Total current liabilities	152,075	16,608
Non-current liabilities
Operating lease liability, non-current	3,541
Accrued workers’ compensation costs	1,227	1,646
Non-current liabilities of discontinued operations	3,269	3,765
Total liabilities	160,112	22,019
Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock, 50,000,000 authorized shares; $0.0001 par value: 8,600,000 and 0 shares issued and outstanding as of August 31, 2022 and August 31, 2021.	1	0
Common stock, 750,000,000 authorized shares; $0.0001 par value; 513,349 and 258,631 shares issued as of August 31, 2022 and August 31, 2021	5	3
Additional paid-in capital	151,731	142,786
Accumulated deficit	(192,725)	(149,338)
Total ShiftPixy, Inc. Stockholders' deficit	(40,988)	(6,549)
Non-controlling interest in consolidated subsidiaries (See Note 5)	9,494	47,472
Total Equity (Deficit)	(31,494)	40,923
Total liabilities and equity deficit	$ 128,618	$ 62,942

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Aug. 31, 2022	Aug. 31, 2021
LIABILITIES AND EQUITY (DEFICIT)
Temporary equity, shares outstanding (in shares)	11,500,000	0
Temporary equity, redemption price per share (in dollars per share)	$ 10.15
Stockholders’ equity (deficit)
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	8,600,000	0
Preferred stock, shares outstanding (in shares)	8,600,000	0
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock shares issued (in shares)	513,349	258,631

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Aug. 31, 2022	Aug. 31, 2021
Income Statement [Abstract]
Revenues (See Note 2)	$ 36,002,000	$ 23,420,000
Cost of revenue	34,227,000	23,098,000
Gross profit	1,775,000	322,000
Operating expenses:
Salaries, wages, and payroll taxes	13,575,000	11,100,000
Commissions	89,000	176,000
Professional fees	7,673,000	4,089,000
Research and Software development	2,529,000	3,755,000
Depreciation and amortization	509,000	357,000
Impaired asset expense	4,004,000	0
ROU asset impairment	3,851,000
General and administrative	12,788,000	8,190,000
Total operating expenses	45,018,000	27,667,000
Operating Loss	(43,243,000)	(27,345,000)
Other (expense) income:
Interest expense	(1,000)	(5,000)
Other income	316,000	25,000
Expensed SPAC offering costs	(515,000)	0
Total other expense	(200,000)	20,000
Loss from continuing operations before income taxes	(43,443,000)	(27,325,000)
Income tax expense	(38,000)	42,000
Loss from continuing operations	(43,405,000)	(27,367,000)
Loss from discontinued operations, net of tax	(590,000)	(2,509,000)
Net loss attributable to ShiftPixy, Inc shareholders	(43,995,000)	(29,876,000)
Deemed dividend from change in fair value from warrants modification	(15,703,000)	0
Net loss attributable to common stockholders	$ (59,698,000)	$ (29,876,000)
Net Loss per share, Basic and diluted
Continuing operations, basic (in dollars per share)	$ (148.28)	$ (81.23)
Continuing operations, diluted (in dollars per share)	(148.28)	(81.23)
Discontinued operations, basic (in dollars per share)	(1.47)	(7.44)
Discontinued operations, diluted (in dollars per share)	(1.47)	(7.44)
Net loss per common share, basic (in dollars per share)	(149.75)	(88.67)
Net loss per common share, diluted (in dollars per share)	$ (149.75)	$ (88.67)
Weighted average common shares outstanding, basic (in shares)	402,591	337,225
Weighted average common shares outstanding, diluted (in shares)	402,591	337,225

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	ASC 842 adoption catch up adjustment	Private Placement	Underwritten Public Offering	Offering One Warrants	[1]	Offering Two Warrants	[2]	Parent	Parent ASC 842 adoption catch up adjustment	Parent Private Placement	Parent Underwritten Public Offering	Parent Offering One Warrants	[1]	Parent Offering Two Warrants	[2]	Preferred Stock Issued	Common Stock Issued	Common Stock Issued Private Placement	Common Stock Issued Underwritten Public Offering	Common Stock Issued Offering One Warrants	[1]	Common Stock Issued Offering Two Warrants	[2]	Additional Paid-In Capital	Additional Paid-In Capital Private Placement	Additional Paid-In Capital Underwritten Public Offering	Additional Paid-In Capital Offering One Warrants	[1]	Additional Paid-In Capital Offering Two Warrants	[2]	Accumulated Deficit	Accumulated Deficit ASC 842 adoption catch up adjustment	Noncontrolling Interest
Beginning balance (in shares) at Aug. 31, 2020																	0
Beginning balance at Aug. 31, 2020	$ (30)								$ (30)								$ 0	$ 1							$ 119,431							$ (119,462)		$ 0
Beginning balance (in shares) at Aug. 31, 2020																		169,021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued (in shares)																	12,500		49,485	40,000
Stock issued			$ 11,062	$ 10,701							$ 11,062	$ 10,701							$ 2							$ 11,060	$ 10,701
Common stock issued for note exchange (in shares)																	(12,500)	125
Stock-based compensation expense	1,594								1,594																1,594
Excess fair value of SPACs founder shares transferred to underwriter	47,472																																	47,472
Net Loss	$ (29,876)								(29,876)																							(29,876)
Ending balance (in shares) at Aug. 31, 2021	0																0
Ending balance at Aug. 31, 2021	$ 40,923	$ 608							(6,549)	$ 608							$ 0	$ 3							142,786							(149,338)	$ 608	47,472
Ending balance (in shares) at Aug. 31, 2021	258,631																	258,631
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-02 [Member]
Stock issued (in shares)																	16,600,000		28,500
Stock issued	$ 3,723		$ 4,183						3,723		$ 4,183						$ 2								3,721	$ 4,183
Common stock issued for note exchange (in shares)																	(8,000,000)	80,000			96,218		50,000
Common stock issued on exercised warrants, net of offering costs	0				$ 5,410		$ 1,163		0				$ 5,410		$ 1,163		$ (1)	$ 1			$ 1							$ 5,409		$ 1,163
Prefunded warrants for private placement, net of offering cost	6,861								6,861																6,861
Stock-based compensation expense	1,283								1,283																1,283
Remeasurement of IHC temporary equity	(13,675)								(13,675)																(13,675)
Excess fair value of SPACs founder shares transferred to underwriter	0
Cancellation of non-controlling on withdrawal of SPACs S-1 registration statements	(37,978)																																	(37,978)
Net Loss	$ (43,995)								(43,995)																							(43,995)
Ending balance (in shares) at Aug. 31, 2022	8,600,000																8,600,000
Ending balance at Aug. 31, 2022	$ (31,494)								$ (40,988)								$ 1	$ 5							$ 151,731							$ (192,725)		$ 9,494
Ending balance (in shares) at Aug. 31, 2022	513,349																	513,349

[1]January 26, 2022 Warrant Exercise Agreement[2]J uly 18, 2022, Warrant Exercise Agreemen t

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Aug. 31, 2022	Aug. 31, 2021
OPERATING ACTIVITIES
Net Loss	$ (43,995,000)	$ (29,876,000)
Income (loss) from discontinued operations	(590,000)	(2,509,000)
Net loss from continuing operations	(43,405,000)	(27,367,000)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Bad debt expense	0	45,000
Depreciation and amortization	509,000	357,000
Impaired asset expense	4,004,000	0
ROU asset impairment	3,851,000
Stock-based compensation	1,283,000	1,594,000
Expensed SPAC offering costs	515,000	0
Non-cash lease expense	382,000
Change in fair value of note receivable	0	41,000
Changes in operating assets and liabilities
Accounts receivable	219,000	(235,000)
Unbilled accounts receivable	636,000	(438,000)
Prepaid expenses and other current assets	(152,000)	65,000
Deposits – workers’ compensation	541,000	488,000
Deposits and other assets	25,000	(495,000)
Accounts payable and other accrued liabilities	6,409,000	2,722,000
Payroll related liabilities	8,179,000	2,124,000
Accrued workers’ compensation	(515,000)	565,000
Total Adjustments	25,886,000	6,833,000
Net cash used in continuing operating activities	(17,519,000)	(20,534,000)
Net cash used by discontinued operating activities	(1,000)	(978,000)
Net cash used in operating activities	(17,520,000)	(21,512,000)
INVESTING ACTIVITIES
Purchase of fixed assets	(494,000)	(2,566,000)
Investment of IHC IPO proceeds into Trust Account	(116,969,000)	0
Net cash used in investing activities	(117,463,000)	(2,566,000)
FINANCING ACTIVITIES
Proceeds from initial public offering IHC	116,725,000	0
SPAC offering costs paid	(3,663,000)	(789,000)
Proceeds from Public offering, net of offering costs	0	10,701,000
Proceeds from private placement offering, net of offering costs	4,183,000	11,062,000
Proceeds from exercised warrants, net of offering costs	6,573,000	0
Proceeds from private placement prefunded warrants, net of offering costs	6,861,000	0
Preferred stock issued	3,723,000	0
Net cash provided by financing activities	134,402,000	20,974,000
Net decrease in cash	(581,000)	(3,104,000)
Cash - Beginning of Year	1,199,000	4,303,000
Cash -End of Year	618,000	1,199,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	1,000	14,000
Income taxes	4,000	0
Non-cash Investing and Financing Activities:
Remeasurement of Class A ordinary shares subject to possible redemption	244,000	0
Excess fair value of SPACs founder shares transferred to underwriter	$ 0	$ 47,472,000

Nature of Operations

Nature of Operations	12 Months Ended
Nature of Operations	Aug. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Nature of Operations ShiftPixy, Inc. was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large contingent part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California but has begun to expand into other geographic areas and industries employing temporary or part-time labor sources. The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly-owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly-owned subsidiaries, ShiftPixy Staffing, Inc (“Staffing”). These subsidiaries provide a variety of services to our clients, (as a co-employer through HCM and a direct employer through Staffing), including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). We expect that our HRIS platform will continue to develop as necessary and appropriate to accommodate client needs for additional value-added services. In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly-owned subsidiary of the Company, pursuant to which it assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations . On March 31, 2021, shareholders representing a majority of the Company’s outstanding shares of capital stock approved an amendment to the Company’s Amended and Restated Articles of Incorporation (the “Amendment”) making the federal district courts of the United States the exclusive forum for the resolution of any complaint asserting a cause of action against the Company arising under the Securities Act of 1933, as amended. On May 13, 2021, the Company filed the Amendment with the Wyoming Secretary of State. Effective August 31, 2022, ShiftPixy, Inc. (the “Company”) filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding shares of Common Stock. The reverse split became effective on Nasdaq September 1, 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Aug. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”). Principles of Consolidation The Consolidated Financial Statements include the accounts of ShiftPixy, Inc., and its wholly-owned subsidiaries. The Consolidated Financial Statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of our 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity ). All intercompany balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include: • Valuation related to Preferred stocks; • Liability for legal contingencies; • Useful lives of property and equipment; • Deferred income taxes and related valuation allowance; • Valuation of illiquid non-controlling interest in SPAC shares transferred; • Valuation of long-lived assets including long term notes receivable; and • Projected development of workers’ compensation claims. Revenue and Direct Cost Recognition On September 1, 2020, we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. Our revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and we did not have any significant changes in our business processes or systems. The Company’s revenues are primarily disaggregated in fees for providing staffing solutions and EAS/human capital management services. The Company enters into contracts with its clients for staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months but are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts our performance towards complete satisfaction of the performance obligation. Staffing Solutions The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes. EAS Solutions EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums. Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets, and were $2,105,000 and $2,741,000, as of August 31, 2022, and August 31, 2021, respectively. Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs. The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price. Disaggregation of Revenue The Company’s primary revenue streams include HCM and staffing services. The disaggregated Company’s revenues for Fiscal 2022 and Fiscal 2021 was as follows: Revenue (in millions): 2022 2021 HCM 1 $ 6.4 $ 8.2 Staffing 29.6 15.2 36.0 23.4 1 HCM revenue is presented net, $52.2 million gross less worksite employees payroll cost of $45.8 million for Fiscal 2022 and $63.8 million gross less worksite employees payroll cost of $55.6 million in Fiscal 2021.The Company is developing the ShiftPixy Labs, which is intended to launch multiple restaurants brands in the near future, however no revenue from this initiative has been earned as of the end of Fiscal 2022. For Fiscal 2022 and Fiscal 2021, the following geographical regions represented more than 10% of total revenues: Region: 2022 2021 California 52.1 % 70.3 % Washington 13.3 % 10.8 % Incremental Cost of Obtaining a Contract Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s Consolidated Statements of Operations. Segment Reporting Prior to Fiscal 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting . The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis between Staffing and HCM services and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. See also Disaggregation of Revenue , above. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no such investments as of August 31, 2022, or August 31, 2021. Marketable Securities Held in Trust Account As of August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IBC") or redemption of the public common shares of IHC. Concentration of Credit Risk The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances. As of August 31, 2022, there was $614,900 of cash on deposit in excess of the amounts insured by the FDIC. The Company had no individual clients that represented more than 10% of its annual revenues in Fiscal 2022. For Fiscal 2021, two individual clients represented more than 10% of the Company's annual revenues. As of August 31, 2022, and August 31, 2021, the Company had five clients that represented 96% and four clients representing approximately 94% of its total accounts receivable, respectively. Fixed Assets Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term. Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows: Equipment: 5 years Furnitures & Fixtures: 5 - 7 years Leasehold improvements Shorter of useful life or the remaining lease term, typically 5 years The amortization of these assets is included in depreciation expense on the consolidated statements of operations. Computer Software Development Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software . Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three The Company determined that there were no material internal software development costs for Fiscal 2022 or Fiscal 2021. The Company also expenses internal costs related to minor upgrades and enhancements, as it is impractical to separate these costs from normal maintenance activities. The Company incurred research and development costs for the Fiscal 2022 and Fiscal 2021, of approximately $4.1 million and $6.8 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application. Lease Recognition In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the Statement of Operations. The Company adopted the standard on December 1, 2021, with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021. The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company. The standard had a material effect on the Company’s Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Consolidated Balance Sheet for the Company's office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities. Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases. Impairment and Disposal of Long-Lived Assets The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment . ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company’s long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. Tests for impairment or recoverability require significant management judgment, and future events affecting cash flows and market conditions could result in impairment losses. For Fiscal 2022, the Company recorded a long-lived asset impairment charge on its Note receivable of approximately $4.0 million and a right of use asset impairment of $3.9 million recorded in the operating expenses of the Consolidated Statements of Operations. See Note 3, Discontinued Operations and Note15 Commitments. Workers’ Compensation Everest Program Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 16, Contingencies, Everest Litigation , below. Sunz Program From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided through an arrangement with United Wisconsin Insurance Company and administered by the Sunz Insurance Company. Under this program, the Company has financial responsibility for the first $500,000 of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in its consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 16, Contingencies , Sunz Litigation , below. Current Program Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria. Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. Balance Sheet Items Related To Workers’ Compensation Under both the Everest and Sunz Programs, the Company utilized a third-party to estimate its loss development rate, which is based primarily upon the nature of WSE job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. As of August 31, 2022, the Company had no Deposit – workers’ compensation classified as a short-term or as a long-term asset related to any of these programs. The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.6 million and long term accrued workers’ compensation costs of $1.2 million. The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, part of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of August 31, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of August 31, 2022, the Company had $1.4 million of short term liabilities and $3.3 million of long term liabilities, with no short or long term assets. Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs which are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan. The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on our workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after August 31, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues. Debt Issuance Costs and Debt Discount Debt issuance costs and debt discounts are being amortized over the lives of the related financings on a basis that approximates the effective interest method. Costs and discounts are presented as a reduction of the related debt in the accompanying consolidated balance sheets. Portions attributable to notes converted into equity are accelerated to interest expense upon conversion. Fair Value of Financial Instruments ASC 820, Fair Value Measurement , requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of August 31, 2022, and August 31, 2021, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at our estimate of expected collections value as described below and in Note 3, Discontinued Operations . The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are: • Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. • Level 2: Inputs to the valuation methodology include: ◦ Quoted prices for similar assets or liabilities in active markets; ◦ Quoted prices for identical or similar assets or liabilities in inactive markets; ◦ Inputs other than quoted prices that are observable for the asset or liability; ◦ Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and ◦ If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. • Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. As of August 31, 2022, and August 31, 2021, the Company valued the Note Receivable as discussed in Note 3, Discontinued Operations , below. Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying Consolidated Balance Sheet. The Company did not have other Level 1 or Level 2 assets or liabilities at August 31, 2022, or August 31, 2021. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of our sponsored SPACs being consummated. See also Note 5, Special Purpose Acquisition company (SPAC) and Note 6, Deferred Offering Costs – SPACS , below. When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. For the periods ended August 31, 2022, and August 31, 2021, there were no transfers of financial assets or financial liabilities between the hierarchy levels. Advertising Costs The Company expenses all advertising as incurred. The Company recorded expenses totaling $2.5 million and $2.6 million for Fiscal 2022 and Fiscal 2021, respectively. Income Taxes The Company accounts for income taxes pursuant to ASC 740, Income Taxes . Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. Stock-Based Compensation As of August 31, 2022, and August 31, 2021, the Company had one stock-based compensation plan under which the Company may issue both share and stock option awards. The Company accounts for this plan under the recognition and measurement principles of ASC 718, Compensation- Stock Compensation , which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations at their fair values. Share grants are valued at the closing market price on the date of issuance, which approximates fair value. For option grants, the grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. Option grants are typically issued with vesting depending on a term of service. For all employee stock options granted, the Company recognizes expense over the employee’s requisite service period (generally the vesting period of the equity grant). The Company’s option pricing model re

Discontinued Operations

Discontinued Operations	12 Months Ended
Discontinued Operations	Aug. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations On January 3, 2020, the Company executed an asset purchase agreement assigning client contracts comprising approximately 88% of its quarterly revenue through the date of the transaction, including 100% of its existing professional employer organization (“PEO”) business effective as of December 31, 2019, and transferring $1.5 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement, to a wholly owned subsidiary of Vensure (the “Vensure Asset Sale”). Gross proceeds from the Vensure Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was scheduled to be paid out in equal monthly payments over the four years following the closing of the transaction (the “Note Receivable”), subject to adjustments for working capital and customer retention, (as measured by a gross wage guarantee included in the governing agreement), over the twelve month period following the Vensure Asset Sale. For Fiscal 2022 and Fiscal 2021, the Company recorded the Note Receivable based on the estimate of expected collections based on additional information obtained through discussions with Vensure and evaluation of our records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the impact of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments, and maintains that the amount Vensure owes the Company pursuant to the Note Receivable is as much as $9.5 million. The Company assessed the collectibility of this note during its third quarter reporting of Fiscal 2022and determined that it was probable that all contractually required payments will not be collected and recorded a reserve on collectibility of approximately $4.0 million. The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at Note 16, Contingencies , Vensure Litigation , below. The following is a reconciliation of the gross proceeds to the net Note Receivable from the Vensure Asset Sale as presented on the Company’s consolidated balance sheet for Fiscal 2022. Gross proceeds $ 19,166,000 Cash received at closing – asset sale (9,500,000) Cash received at closing – working capital (166,000) Gross note receivable $ 9,500,000 Less: Transaction reconciliation – estimated working capital adjustment (2,604,000) Adjusted note receivable 6,896,000 Less: Reserve for estimated potential claims (2,892,000) Less: Reserve on potential collectibility (4,004,000) Long-term note receivable $ — The Note Receivable was recorded as a long term note receivable as of August 31, 2021. The estimates of the working capital and gross billings adjustments would not result in any cash payments due to the Company as of Fiscal 2022 or Fiscal 2021. The Vensure Asset Sale generated a gain of $15.6 million for Fiscal 2021. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance. The Vensure Asset Sale met the criteria of discontinued operations The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount. (i) Working capital adjustments : Through August 31, 2021, the Company has identified $2.6 million of likely working capital adjustments, including $0.1 million related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of August 31, 2022, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon our internal records and best estimates. There is no assurance that the working capital change identified as of August 31, 2022, represents the final working capital adjustment. (ii) Gross billings adjustment : Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve during Fiscal 2021. No additional adjustment was made during Fiscal 2022. The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows: August 31, August 31, Deposits – workers’ compensation $ — $ 356,000 Total current assets — 356,000 Deposits – workers’ compensation — 883,000 Total assets $ — $ 1,239,000 Accrued workers’ compensation cost $ 1,362,000 $ 1,516,000 Total current liabilities 1,362,000 1,516,000 Accrued workers’ compensation cost 3,269,000 5,411,000 Total liabilities 4,631,000 6,927,000 Net liability $ (4,631,000) $ (5,688,000) Reported results for the discontinued operations by period were as follows: For the Year Ended August 31, 2022 August 31, 2021 Revenues $ — $ — Cost of revenue 590,000 2,509,000 Gross profit (590,000) (2,509,000) Operating expenses: Salaries, wages and payroll taxes — — Commissions — — Total operating expenses — — (Loss) income from discontinued operations $ (590,000) $ (2,509,000) During Fiscal 2022, the Company recorded net operating loss from discontinued operations totaling $0.6 million, that were fully reserved for income tax. During Fiscal 2021, the Company recorded net operating loss from discontinued operations totaling $8,632,000 that were fully reserved for income tax. The components of income tax expense for discontinued operations are as follows: For the Year Ended 2022 2021 Provision for income tax benefits Federal tax benefits $ (114,000) $ (500,000) State tax benefits (45,000) (129,000) Total tax benefits (159,000) (629,000) Valuation allowance on loss carryforwards 159,000 629,000 Provision for income tax expense from discontinued operations $ — $ —

Going Concern

Going Concern	12 Months Ended
Going Concern	Aug. 31, 2022
Risks and Uncertainties [Abstract]
Going Concern	Going Concern The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. As of August 31, 2022, the Company had cash of $0.6 million and a working capital deficit of $31.2 million. See Note 9, Workers’ Compensation; Note 10, Accrued Payroll and Related Liabilities; and Note 15 , Commitments . During this period, the Company used approximately $17.5 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $192.7 million as of August 31, 2022. As of August 31, 2022, the Company is delinquent with respect to remitting payroll tax payments to the IRS. See Note 10: Accrued Payroll and Related Liabilities . The Company has been in communication with the IRS regarding amounts owing in relation to credits due. In addition, some clients have filed suits against the Company, demanding that the Company take action to seek additional ERTC tax credits for the subject periods. Until the matter is concluded and the taxes are paid, the IRS could, subject to its standard processes and the Company’s rights to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing. Historically, our principal source of financing has come through the sale of our common stock and issuance of convertible notes. In September 2021, we raised approximately $12 million ($11.1 million net of costs) in connection with the sale of common stock and warrants; in January 2022, we entered into a warrant exercise agreement that raised approximately $5.9 million ($5.4 million net of costs), and in July 2022, we entered into a warrant exercise agreement that raised approximately $1.3 million ($1.2 million net of costs). See Note 11, Stockholders' Equity (Deficit). The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. Our plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations and strengthening of our sales force strategy by focusing on staffing services as our key driver to improve our margin and the continued support and functionality improvement of our information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. We expect to continue to invest in our HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures. The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create value for its shareholders. The Company expects to engage in additional sales of its securities during Fiscal 2023, either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. The Company’s management believes that its current cash position, along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, will alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful on obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. These consolidated financial statements do not include any adjustments for this uncertainty.

Special Purpose Acquisition Com

Special Purpose Acquisition Company ("SPAC") Sponsorship	12 Months Ended
Special Purpose Acquisition Company ("SPAC") Sponsorship	Aug. 31, 2022
Investments in and Advances to Affiliates [Abstract]
Special Purpose Acquisition Company ("SPAC") Sponsorship	Special Purpose Acquisition Company ("SPAC") Sponsorship On April 29, 2021, we announced our sponsorship, through our wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments"), of four SPACs. Each SPAC was seeking to raise approximately $150 million in capital investment, through an IPO, to acquire companies in the healthcare and technology segments of the staffing industry, as well as one or more insurance entities. On March 18, 2022, the IPO registration statements related to the three other SPACs we had sponsored, Vital Human Capital, Inc. ("Vital"), TechStackery, Inc. ("TechStackery"), and Firemark Global Capital, Inc. ("Firemark"), were withdrawn. With the withdrawal of these IPO registrations, the Company recorded approximately $38.0 million of deferred costs against Non-controlling interest. The registration statement and prospectus covering the IPO of IHC was declared effective by the SEC on October 19, 2021, and IHC Units, consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the New York Stock Exchange (“NYSE”) on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, we purchased, through our wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. Following the closing of the IPO, the sum of $116,725,000 was placed in a trust account (the “Trust Account”), and was invested in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "ICA"), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the ICA, as determined by the Company, until the earlier of: (i) the completion of the IBC and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The $116,725,000 consisted of the $115,000,000 of gross proceeds from the sale of the IHC Units in the IPO and $1,725,000 funded by the Company, as the corporate parent of the Sponsor, representing guaranteed interest for future redemptions and calculated as one year's interest at 1.5%. With the completion of the IPO, the Company recorded approximately $9.5 million of deferred costs in APIC, and $0.3 million of offering costs paid on behalf of IHC. During Fiscal 2022, IHC incurred approximately $3.5 million in offering costs. No other offering costs have been incurred during the period for the withdrawn SPACs. The Trust Account generated interest and dividend income for the Fiscal 2022 of approximately $0.02 million. After completion of its IPO, IHC sought to acquire companies in the light industrial segment of the staffing industry. Upon the completion of IHC's IPO, through our wholly-owned subsidiary, we owned approximately 15% of its issued and outstanding stock. Furthermore, we anticipated that IHC would operate as a separately managed, publicly traded entity following the completion of its IBCs. The operations of IHC have been consolidated in the accompanying financial statements for the reasons set forth above in Note 2, Summary of Significant Accounting Policies. On October 14, 2022, the stockholders of IHC, approved the proposed action to file an amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State of Delaware. In connection with the meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. leaving 248,653 of the Company’s remaining Public Shares outstanding and the Trust Account substantially below the $5,000,001 minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. The board of directors of IHC accordingly adopted resolutions to liquidate, dissolve and unwind the entity. See Note 17, Subsequent Events. Since IHC was dissolved on November 14, 2022, and since the Trust released all the redemption funds to shareholders on December 2, 2022, effectively liquidating the Trust, we will evaluate the impact including de-consolidation of its operations during our first quarterly reporting for our Fiscal 2023.

Deferred Offering Costs - SPACs

Deferred Offering Costs - SPACs	12 Months Ended
Deferred Offering Costs - SPACs	Aug. 31, 2022
Noncontrolling Interest [Abstract]
Deferred Offering Costs - SPACs	Deferred Offering Costs - SPACs During Fiscal 2021, the Company incurred professional fees related to the filing of registration statements for the IPOs of four SPACs. The Company also transferred certain Founder Shares of those SPACs to a third party which created a non-controlling interest in those entities. These Founder Shares of common stock were transferred to the SPACs’ underwriter representative (the “Representative”) at below fair market value, resulting in compensation and therefore deferred offering costs for the SPACs, and the creation of a minority interest. The non-controlling interest is recorded as a minority interest on the Balance Sheet and the Statement of Equity. As of August 31, 2021, Deferred offering costs - SPACs totaled $48,261,000, consisting of $789,000 of legal and accounting fees related to the SPACs’ IPOs and $47,472,000 related to the non-controlling interest in consolidated subsidiaries. The non-controlling interest – deferred offering costs represents the estimated value of the portion of our Founder Shares in each of the following SPACs that we received as a result of our sponsorship, and which we transferred to the Representative on April 22, 2021, at a price below the fair market value of the shares, as follows: (i) 2,000,000 shares of IHC common stock; (ii) 2,000,000 shares of TechStackery common stock; (iii) 2,000,000 shares of Vital common stock; and (iv) 4,000,000 shares of Firemark common stock. We estimate the total value of the 10,000,000 shares transferred, which represents deferred compensation to the Representative, to be $47,472,000, or $4.7472 per share. We arrived at this valuation by reference to similar SPAC IPO transactions, as set forth below: 1. Consistent with most SPAC IPOs, the market price of units (consisting of some combination of common stock and warrants) sold to the public in a SPAC IPO is $10 per unit. 2. We have valued the warrant portion of each Unit at $0.75. Deducting this value from the Unit yields a value of $9.25 per share of common stock at the time of the IPO, which we have applied to the value of each of the Founder Shares that we issued to the Representative. 3. We have applied a further discount of 48.8%, which is a blended discount designed to reflect the following contingencies and uncertainties: (a) 20% probability that the SPAC IPOs are never consummated; (b) 20% probability that none of our sponsored SPACs successfully complete their IBC; and (c) 21% additional discounts to account for future sponsor and Representative concessions, as well as the possibility of decrease in the value of the common stock of each SPAC. One of the Company's sponsored SPACs, IHC, completed its IPO on October 22, 2021, resulting in the recognition of approximately $13 million of offering costs, including $9.8 million that had been deferred as of August 31, 2021 in APIC. No offering costs were incurred for TechStackery, Vital, or Firemark during the quarter ended May 31, 2022, as these company's registration statements were withdrawn. As discussed in Note 5, Special Purpose Acquisition Company ("SPAC") Sponsorship,

Accounts Receivable

Accounts Receivable	12 Months Ended
Accounts Receivable	Aug. 31, 2022
Receivables [Abstract]
Accounts Receivable	Accounts Receivable Accounts receivable represent outstanding gross billings to clients, and are reported net of allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of specific accounts and by making a general provision, based on its past experiences, for other potentially uncollectible amounts. The provision for doubtful accounts during Fiscal 2022 and Fiscal 2021 was not material. Write-offs for Fiscal 2022 and Fiscal 2021 were $0 and $45,000, respectively. The Company makes an accrual at the end of each accounting period for the obligations associated with the earned but unpaid wages of its WSEs and for the accrued gross billings associated with such wages. These accruals are included in unbilled accounts receivable. The Company generally requires clients to pay invoices for service fees no later than 1 day prior to the applicable payroll date. As such, the Company generally does not require collateral.

Fixed Assets

Fixed Assets	12 Months Ended
Fixed Assets	Aug. 31, 2022
Property, Plant and Equipment [Abstract]
Fixed Assets	Fixed Assets Fixed assets consisted of the following at August 31, 2022, and August 31, 2021: August 31, August 31, Equipment 2,700,000 2,386,000 Furniture & fixtures 614,000 599,000 Leasehold improvements 710,000 545,000 4,024,000 3,530,000 Accumulated depreciation & amortization (1,255,000) (746,000) Fixed assets, net $ 2,769,000 $ 2,784,000 Depreciation and amortization expense for Fiscal 2022 and Fiscal 2021 was $509,000 and $357,000, respectively. Software consists primarily of customized software purchased from third-party providers, which is incorporated into the Company’s HRIS platform and related mobile application. The Company has evaluated certain development costs of its software solution in accordance with ASC Topic 350-40, Internal Use Software

Workers' Compensation

Workers' Compensation	12 Months Ended
Workers' Compensation	Aug. 31, 2022
Compensation Related Costs [Abstract]
Workers Compensation	Workers’ Compensation The Company had three workers’ compensation programs in effect at various points during Fiscal 2022 and Fiscal 2021. The Everest program covered corporate employees and WSEs from July 1, 2017 through June 30, 2018 and the SUNZ program covered corporate employees and WSEs from July 1, 2018 through February 28, 2021. Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program, pursuant to which the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria. The following table summarizes the workers’ compensation deposit from continuing operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Deposit at August 31, 2020 $ — 1,029,000 $ 1,029,000 Premiums paid — — — Paid in deposits — 446,000 446,000 Claim losses — (934,000) (934,000) Deposit refund — — — Workers’ Comp Deposit at August 31, 2021 $ — 541,000 $ 541,000 Paid in deposits — — — Claim losses — (541,000) (541,000) Workers’ Comp Deposit at August 31, 2022 — — — Less Current Amount — — — Long Term Balance at August 31, 2022 $ — — $ — The following table summarizes the workers’ compensation deposit from discontinued operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Deposit at August 31, 2020 $ — 3,611,000 $ 3,611,000 Premiums paid — — — Paid in deposits — 1,062,000 1,062,000 Claim losses — (3,434,000) (3,434,000) Deposit refund — — — Workers’ Comp Deposit at August 31, 2021 $ — 1,239,000 $ 1,239,000 Paid in deposits — — — Claim losses — (1,239,000) (1,239,000) Workers’ Comp Deposit at August 31, 2022 — — — Less Current Amount — — — Long Term Balance at August 31, 2022 $ — — $ — The following table summarizes the accrued workers’ compensation liability from continuing operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Liability at August 31, 2020 $ 204,000 1,541,000 $ 1,745,000 Claim loss development 50,000 1,273,000 1,323,000 Paid in losses — (760,000) (760,000) Workers’ Comp Liability at August 31, 2021 $ 254,000 2,054,000 $ 2,308,000 Claim loss development 101,000 (130,000) (29,000) Paid in losses — (541,000) (541,000) Workers’ Comp Liability at August 31, 2022 355,000 1,383,000 1,738,000 Less Current Amount (135,000) (376,000) (511,000) Long Term Balance at August 31, 2022 $ 220,000 1,007,000 $ 1,227,000 The following table summarizes the accrued workers’ compensation liability from discontinued operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Liability at August 31, 2020 $ 717,000 5,405,000 $ 6,122,000 Claim loss development 103,000 2,639,000 2,742,000 Paid in losses — (3,583,000) (3,583,000) Workers’ Comp Liability at August 31, 2021 $ 820,000 4,461,000 $ 5,281,000 Claim loss development 130,000 459,000 589,000 Paid in losses — (1,239,000) (1,239,000) Workers’ Comp Liability at August 31, 2022 950,000 3,681,000 4,631,000 Less Current Amount (361,000) (1,001,000) (1,362,000) Long Term Balance at August 31, 2022 $ 589,000 2,680,000 $ 3,269,000 The Company is currently engaged in litigation regarding a demand for additional premium payments from Everest and additional claims loss funds from Sunz, which we believe to be without merit, as discussed at Note 16, Contingencies, Everest and Sunz Litigation , below.

Accrued Payroll and Related Lia

Accrued Payroll and Related Liabilities	12 Months Ended
Accrued Payroll and Related Liabilities	Aug. 31, 2022
Accrued Payroll and Related Liabilities
Accrued Payroll and Related Liabilities	Accrued Payroll and Related Liabilities Accrued payroll liabilities consisted of the following at August 31, 2022, and August 31, 2021: August 31, August 31, Accrued Payroll $ 2,270,000 $ 2,438,000 Accrued Payroll Taxes 13,278,000 4,758,000 Corporate employee accrued paid time off 506,000 680,000 Accrued Payroll and related liabilities $ 16,054,000 $ 7,876,000

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
Stockholders' Equity (Deficit)	Aug. 31, 2022
Equity [Abstract]
Stockholders' Equity (Deficit)	Stockholders’ Equity (Deficit) Preferred Stock As previously disclosed, in September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. The Preferred Options became exercisable upon the consummation of the Vensure Asset Sale in January 2020, as discussed above. During Fiscal 2020, the Company recorded an expense of $62.1 million, related to the triggering of the Preferred Options as other expense, which was calculated pursuant to the Black-Scholes-Merton methodology applicable to valuing the 24,634,560 Preferred Options that became exercisable and exchangeable into an equal number of shares of common stock. The Company evaluated the Preferred Options on the same date using Level 2 inputs based on the offering price of the Company’s common stock and warrants issued in connection with its May 2020 Public Offering, as adjusted for the fair value of the warrants issued in conjunction with said public offering. The resulting allocated common share price was then discounted for a lack of marketability of shares subject to “lock-up” agreements entered into in connection with the May 2020 Public Offering, which yielded a fair value of $2.52 per Preferred Option. The Company used the following assumptions to value the expense related to the Preferred Options: (i) option life of 3.77 years; (ii) risk free rate of 0.47%; (iii) volatility of 134%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $3.62 per share of the Company’s common stock. On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of our preferred stock for an aggregate purchase price of $1,250. Immediately following the exercise of the Preferred Options described above, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which were subject to a 24-month lock-up period during which such shares may not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which were subject to a six-month lock up period at the time they were issued, during which such shares could not be traded on the open market. As of August 31, 2022, the restrictions on 294,490 of these shares have been lifted, rendering them freely tradable. On October 22, 2021, the Company’s board of directors canceled the remaining 11,790,000 of these Preferred Options previously issued to its co-founder, J. Stephen Holmes, pursuant to the September 2016 grant. Accordingly, these Preferred Options are no longer exercisable. See Note 16 Contingencies and Note 17 Subsequent Events. The amount of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of Preferred Options granting an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 per share, for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert, (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act. On July 14, 2022, the Board of the Company approved the issuance to the Company’s founder and principal shareholder, Scott Absher, of 12,500,000 shares of the Company’s Preferred Class A Stock ("Preferred Shares"), par value $0.0001 per share, in exchange for (a) the surrender by Mr. Absher of his options to acquire 12,500,000 Preferred Shares, which Preferred Options provide for exercise upon certain triggering events as described above, and as detailed in our prior filings, and (b) the tender of payment by Mr. Absher of the sum of $5,000, representing four times the par value for such Preferred Shares. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2322 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.06%; (iii) volatility of 125.664%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.2580 per share of the Company’s common stock. These were recorded as compensation expense in the general and administrative expenses in the Consolidated Statements of Operations. On July 19, 2022, Mr. Absher converted 8,000,000 shares of the Preferred Shares to 8,000,000 shares of the Company’s Common Stock, par value $0.0001 per share. Pursuant to Rule 144, these 8,000,000 shares of Common Stock are subject to a six-month holding period during which they may not be sold in the marketplace. A remaining 4,500,000 Preferred Shares were still outstanding as of August 31, 2022. On August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $820,793.24, in exchange for an option to receive 4,100,000 shares of the Company's Preferred Class A Stock. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2025 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 2.970%; (iii) volatility of 125.700%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.2250 per share of the Company’s common stock. Pursuant to Rule 144, these 4,100,000, when converted into shares of Common Stock are subject to a six-month holding period during which they may not be sold in the marketplace. October 2020 Public Offering On October 8, 2020, the Company entered into an underwriting agreement (the “October Underwriting Agreement”) with AGP in connection with a public offering (the “October 2020 Offering”) of an aggregate of (i) 40,000 shares of our common stock and (ii) warrants to purchase 23,000 shares of common stock (the “October 2020 Common Warrants”), which included the partial exercise of AGP’s over-allotment option to purchase 3,000 additional October 2020 Common Warrants. Each share of common stock was sold together with an October 2020 Common Warrant as a fixed combination, with each share of common stock sold being accompanied by an October 2020 Common Warrant to purchase 0.5 shares of common stock. Each share of common stock and accompanying October 2020 Common Warrant was sold at a price to the public of $300.00. The October 2020 Common Warrants were immediately exercisable, will expire on October 13, 2025, and have an exercise price of $330.00 per share, subject to anti-dilution and other adjustments for certain stock splits, stock dividends, or recapitalizations. The October 2020 Offering closed on October 14, 2020, for gross proceeds of approximately $12.0 million, prior to deducting $1.3 million of costs consisting of underwriting discounts and commissions and offering expenses payable by the Company, which includes a partial exercise of the underwriter’s over-allotment option to purchase additional October 2020 Common Warrants. Pursuant to the October Underwriting Agreement, the Company, upon closing of the October 2020 Offering, issued to AGP warrants to purchase up to 2,000 shares of common stock (the “October Underwriter Warrants”), which is equivalent to 5.0% of the aggregate number of shares of common stock sold in the October 2020 Offering. The October Underwriter Warrants are exercisable at any time and from time to time, in whole or in part, commencing six months after the closing date and ending 5 years from the closing date, at a price per share equal to $330.00, which is equivalent to 110% of the public offering price per share. The Company accounts for the warrants as equity-classified. May 2021 Private Placement On May 17, 2021, the Company closed a private placement with a large institutional investor pursuant to which it sold to the investor an aggregate of (i) 23,200 shares of the Company’s common stock, par value $0.010 per share (the “Common Stock”), together with warrants (the “May 2021 Common Warrants”) to purchase up to 23,200 shares of Common Stock, with each May 2021 Common Warrant exercisable for one share of Common Stock at a price per share of $242.50, and (ii) 26,285 prefunded warrants (the “May 2021 Prefunded Warrants”), together with the May 2021 Common Warrants to purchase up to 26,285 shares of Common Stock, with each May 2021 Prefunded Warrant exercisable for one share of Common Stock at a price per share of $0.010. Each share of Common Stock and accompanying May 2021 Common Warrant were sold together at a combined offering price of $242.50 and each May 2021 Prefunded Warrant and accompanying May 2021 Common Warrant were sold together at a combined offering price of $242.49. The May 2021 Prefunded Warrants are immediately exercisable, at a nominal exercise price of $0.010, and may be exercised at any time until all of the May 2021 Prefunded Warrants are exercised in full. The May 2021 Common Warrants have an exercise price of $242.5 per share, are immediately exercisable, and will expire five years from June 15, 2021, which is the date that the registration statement covering the resale of the shares underlying the Common Warrants was declared effective. The private placement generated gross proceeds of approximately $12.0 million, prior to deducting $0.94 million of costs consisting of Placement Agent commissions and offering expenses payable by the Company. In addition to the seven percent (7.0%) of the aggregate gross proceeds cash fee, the Company issued to the Placement Agent warrants to purchase an aggregate of up to five percent (5%) of the aggregate number of shares of Common Stock issuable upon exercise of the May 2021 Prefunded Warrants sold in the private placement (the “May Placement Agent Warrants”). The May Placement Agent Warrants are exercisable for a period commencing on November 17, 2021 (six months after issuance), expire June 15, 2025, and have an initial exercise price of $266.75 per share. September 2021 Private Placement In September 2021, the Company entered into a $12 million private placement transaction, inclusive of $0.9 million of placement agent fees and costs, with a large institutional investor pursuant to which the Company sold to the investor an aggregate of (i) 28,500 shares of Common Stock, together with warrants (the “September 2021 Common Warrants”) to purchase up to 28,500 shares of Common Stock, with each September 2021 Common Warrant exercisable for one share of Common Stock at a price per share of $159.50, and (ii) 46,735 prefunded warrants (the “September 2021 Prefunded Warrants”), together with the September 2021 Common Warrants to purchase up to 75,235 shares of Common Stock, with each September 2021 Prefunded Warrant exercisable for one share of Common Stock at a price per share of $0.010. Each share of Common Stock and accompanying September 2021 Common Warrant were sold together at a combined offering price of $159.50 and each September 2021 Prefunded Warrant and accompanying September 2021 Common Warrant were sold together at a combined offering price of $159.49. The September 2021 Prefunded Warrants are immediately exercisable, at a nominal exercise price of $0.010, and may be exercised at any time until all of the September 2021 Prefunded Warrants are exercised in full. The September 2021 Common Warrants have an exercise price of $159.50 per share, are immediately exercisable, and will expire five years from the date that the registration statement covering the resale of the shares underlying the September 2021 Common Warrants is declared effective (which has not yet occurred). The private placement generated gross proceeds of approximately $12.0 million, prior to deducting $0.9 million of costs consisting of placement agent commissions and offering expenses payable by the Company. In addition to the seven percent (7%) of the aggregate gross proceeds cash fee, the Company issued to the placement agent warrants to purchase $3,762 shares of our common stock issuable upon exercise of the September 2021 Prefunded Warrants sold in the offering (the “September Placement Agent Warrants”). The September Placement Agent Warrants are exercisable for a period commencing on March 3, 2022 (six months after issuance) and expire four years from the effective date (which occurred on May 3, 2022) of a registration statement for the resale of the underlying shares, and have an initial exercise price per share of $175.45. The Company accounts for the warrants as equity-classified. January 2022 Warrant Exercise Agreement On May 17, 2021, we issued warrants to purchase up to an aggregate of 49,485 shares of our common stock, par value $0.0001 with an exercise price of $242.50 (the "Existing Warrants"). The Existing Warrants were immediately exercisable and expire on June 15, 2026. On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the Exercise Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 49,485 of its Existing Warrants (the "Investor Warrants") into shares of our common stock (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $120.00 and (ii) provided for the issuance of a new warrant to purchase up to an aggregate of approximately 98,969 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $155.00. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $461,000 of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $639,000 for the increased fair value of the modified warrants; and (ii) $12,590,000 as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5,477,000 as issuance costs that offset the $5.5 million of additional paid-in capital the Company received for the cash exercise of the Existing Warrants at the reduced exercise price, while the remaining $7,731,000 was recorded as a deemed dividend on the Consolidated Statements of Operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation. The Company accounts for the warrants as equity-classified. July 19, 2022 Warrant Exercise Agreement On July 18, 2022, the Company entered into a warrant exercise agreement (the “Exercise Agreement”) with the holder of the September 2021 Warrants and January 2022 Warrants (the “Exercising Holder”). Pursuant to the Exercise Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise for cash 50,000 of its September 2021 Warrants (the “Investor Warrants”). In order to induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amends the September 2021 Warrants and January 2022 Warrants to (a) reduce the exercise price per share of the September 2021 Warrants and January 2022 Warrants to $26.00, (b) extends the expiration date of the September 2021 Warrants to May 3, 2029, and (c) extends the expiration date of the January 2022 Warrants to July 28, 2029 and (ii) provides for the issuance by the Company to the Exercising Holder of new warrants to purchase up to 348,408 shares of common stock (the “New Warrants”) (equal to 200% of the sum of the September 2021 Warrants and January 2022 Warrants). The New Warrants are exercisable for a period of seven years commencing upon issuance and have an exercise price per share of $26.00. On July 25, 2022, the Company entered into an amendment with the holder of the Company’s warrants to purchase 348,408 shares of common stock, issued July 19, 2022. Pursuant to the amendment, the warrants were amended to be exercisable commencing January 19, 2023 (six months from the date of issuance) and will terminate January 19, 2030. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the July 2022 Common Warrants, the Company recorded approximately (i) $488,700 and $599,700 for the increased fair value of the September 2021 and January 2022 modified warrants, respectively; and (ii) $8,084,000 as the fair value of the July 2022 Common Warrants on the date of issuance. We recorded approximately $100,000 on paid cost and $1,200,000 as issuance costs that offset the $130,000 of additional paid-in capital the Company received for the cash exercise of the Existing Warrants at the reduced exercise price, while the remaining $7,972,500 was recorded as a deemed dividend on the Consolidated Statements of Operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation. The Company accounts for the warrants as equity-classified. Common Stock and Warrants During Fiscal 2022, the Company issued the following securities pursuant to the transactions described above: • 28,500 shares of common stock, prefunded warrants to purchase 46,735 shares of common stocks and warrants to purchase 75,235 common stock pursuant to the September 2021 PIPE. • 49,485 shares of common stock and warrants to purchase 98,969 shares of common stock pursuant to the January 2022 Warrant Exercise Agreement. • 50,000 shares of common stock and warrants to purchase 348,408 common stock in connection with the July 19 2022 Warrant Exercise Agreement. • 8,000,000 Preferred Shares converted into 80,000 shares of the Company’s Common Stock, par value $0.0001 per share. During Fiscal 2021, the Company issued the following securities pursuant to the transactions described above: • 40,000 shares of common stock pursuant to the October 2020 Public Offering at $300.00 per share and warrants to purchase 23,000 shares of common stock. • 23,200 shares of common stock, 26,285 May 2021 Prefunded Warrants and May 2021 Common Warrants to purchase up to 49,485 shares of common stock pursuant to the May 2021 Private Placement. Each share of Common Stock and accompanying May 2021 Common Warrant were sold together at a combined offering price of $242.50, and each May 2021 Prefunded Warrant and accompanying May 2021 Common Warrant were sold together at a combined offering price of $242.49. The following table summarizes the changes in the Company’s issued and outstanding common stock and prefunded warrants from August 31, 2021, to August 31, 2022: Number Weighted Weighted Warrants outstanding, August 31, 2021 95,921 4.4 $ 384 Issued 573,109 7.6 83 (Cancelled) (25) 0 27,600 (Exercised) (146,220) 5.2 — Warrants outstanding, August 31, 2022 522,786 7.2 $ 78 Warrants exercisable, August 31, 2022 174,377 5.8 $ 161 The following tables summarize the Company’s issued and outstanding warrants outstanding as of August 31, 2022: Warrants Weighted average Exercise July 2022 Common Warrants (1) 348,408 7.9 $ 26.00 January 2022 Common Warrants 98,969 6.9 $ 26.00 September 2021 Common Warrants 25,235 6.7 $ 26.00 September 2021 Underwriter Warrants 3,762 6.7 $ 175.00 May 2021 Underwriter Warrants 2,474 3.7 267.00 October 2020 Common Warrants 23,000 3.1 330.00 October 2020 Underwriter Warrants 2,000 3.1 330.00 May 2020 Common Warrants 12,776 2.7 540.00 May 2020 Underwriter Warrants 1,111 2.7 540.00 March 2020 Exchange Warrants 4,237 3.1 1,017.00 Amended March 2019 Warrants 663 1.5 4,000.00 March 2019 Services Warrants 34 1.5 7,000.00 June 2018 Warrants 63 1.3 4,000.00 June 2018 Services Warrants 54 1.3 9,960.00 522,786 7.2 $ 71.00 (1) The July 2022 Common Warrants are not exercisable until January 19, 2023. The number of warrants and exercise price have been presented retroactively for the 1 for 100 reverse stock split, which was effective September 1, 2022, before issuance of the financial statements.

Stock Based Compensation

Stock Based Compensation	12 Months Ended
Stock Based Compensation	Aug. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation	Stock Based Compensation Employee Stock Option Plan Increase In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”), (each of which is exercisable into shares of common stock) (collectively, “Options”) or shares of common stock (“Share Grants”). On July 1, 2020, the Company's board of directors unanimously approved an increase in the number of shares of common stock issuable under the Plan from 250,000 to 3,000,000. On March 31, 2021, the Company’s shareholders approved the increase in the number of shares of common stock issuable under the Plan as well as any contingent grant awards under the Plan on or subsequent to July 1, 2020. On June 4, 2021, the Company filed a registration statement on Form S-8 with the SEC to register the issuance of up to an aggregate of 3,000,000 shares, par value $0.0001 per share, reserved for issuance under the Plan. For all options granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to date have a stated ten-year term and, as of August 31, 2022, all options granted to date are exercisable. Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options and future dividends. Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture. The Company recognized approximately $4,184,267 and $1,593,579 of compensation expense recorded in “Stock-Based Compensation – General and Administrative Expenses" for Fiscal 2022 and Fiscal 2021, respectively. The Company compensates its board members through grants of common stock for services performed. These services have been accrued within the accounts payable and other accrued liabilities on the consolidated balance sheet. The Company has incurred $225,000 and $169,000 for the Fiscal 2022 and Fiscal 2021, respectively. At August 31, 2022, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of three years for outstanding grants was $1,783,000. The following table summarizes the Company’s option grant, exercise and forfeiture activity from August 31, 2020, through August 31, 2022: Options Outstanding and Exercisable Number Weighted Weighted (In years) Balance, August 31, 2020 13,987 9.5 $ 818.00 Granted 8,400 8.5 261.00 Exercised — — — Forfeited (4,626) 5.9 272.00 Balance, August 31, 2021 17,761 8.9 653.00 Granted 1,400 9.8 105.00 Exercised — — — Forfeited (7,409) 8.4 454.00 Balance at August 31, 2022 11,753 8.1 $ 733.00 Options outstanding as of August 31, 2022, and August 31, 2021 had aggregate intrinsic value of $0, respectively. Option vesting activity from August 31, 2020, through August 31, 2022, was as follows: Options Vested Number Weighted Weighted (In years) Balance, August 31, 2020 284 7.2 $ 11,510.00 Vested 2,816 8.8 $ 715.00 Exercised — — $ — Forfeited (8) 6.1 $ 6,717.00 Balance, August 31, 2021 3,092.57 8.6 $ 1,691.00 Vested 4,235 8.6 $ 488.00 Exercised — 0 $ — Forfeited (2,059) 8.1 $ 610.00 Balance at August 31, 2022 5,269 8.1 $ 1,146.00 The following table summarizes information about stock options outstanding and vested at August 31, 2022: Options Outstanding Options Vested Exercise Prices Number Number Weighted Weighted Number Weighted Weighted (In years) (In years) $50.00-1,000.00 — 11,391 8.1 $ 425.00 4,920 8.1 $ 461.00 $1,001.00-$4,000.00 — 20 7.0 1,895.00 17 6.8 1,900.00 $4,001.00–$8,000.00 — 121 6.8 5,121.00 111 6.6 5,120.00 $8,001.00–$12,000.00 — 101 6.0 10,298.00 101 5.7 10,300.00 $12,001.00–$16,000.00 109 5.1 15,584.00 109 4.9 15,590.00 $16,001.00-$39,160.00 — 11 5.1 39,160.00 11 4.9 39,160.00 — 11,753 8.1 $ 733.00 5,269 8.1 $ 1,146.00 The number of options and exercise prices have been presented retroactively for the 1 for 100 reverse stock split, which was effective September 1, 2022.

Related Parties

Related Parties	12 Months Ended
Related Parties	Aug. 31, 2022
Related Party Transactions [Abstract]
Related Parties	Related Parties During Fiscal 2021, we made one-time payments to certain of our employees totaling approximately $650,000 in connection with their agreement to relocate from California to our new principal executive offices in Miami, Florida. Included among these were payments to the following related parties, in the amounts indicated: (i) Scott W. Absher, our board of directors Chair and Chief Executive Officer, $160,000; (ii) Amanda Murphy, our Director of Operations and a member of our Board, $80,000; (iii) David May, a member of our business development team, and the son-in-law of Mr. Absher, $80,000; (iv) Phil Eastvold, the Executive Producer of our wholly owned subsidiary, ShiftPixy Productions, Inc., and the son-in-law of Mr. Absher, $88,000; (v) Hannah Absher, an employee of the Company and the daughter of Mr. Absher, $18,000; and (vi) Jared Holmes, an employee of the Company and son of J. Stephen Holmes, $18,000. Director Compensation Amanda Murphy On February 10, 2020, Amanda Murphy was appointed to our Board. Ms. Murphy was our Director of Operations at the time of her appointment. Ms. Murphy received a salary compensation of $240,000 and $264,152 in Fiscal 2021 and Fiscal 2022, respectively. On October 22, 2021, our Board approved the promotion of Ms. Murphy to the position of Chief Operating Officer, as well as an increase in her annual salary to $500,000, all of which were effective January 1, 2022. As of August 31, 2022, Ms. Murphy has deferred payment related to her salary increase of approximately $157,000. The deferred payment salary is recorded in the accrued liabilities on the Consolidated Balance Sheet. During Fiscal 2021, in connection with her relocation to Miami, Florida as part of the relocation of our principal executive offices, Ms. Murphy received a one-time incentive payment of approximately $80,000 in addition to reimbursement of her expenses associated with her relocation. Scott Absher Scott W. Absher, our CEO and Chair of our Board, received compensation in the form of salary of approximately $764,673 and $750,000 for Fiscal 2022 and Fiscal 2021, respectively. On October 22, 2021, our Board approved raising Mr. Absher’s annual salary to $1,000,000, effective January 1, 2022, and also approved the payment of a $500,000 bonus to Mr. Absher, 50% of which was payable upon Board approval, and the remainder of which was payable on January 1, 2022. As of August 31, 2022, Mr. Absher received payment of 50% of his bonus, or $250,000, in March 2022. Furthermore, as discussed in Note 11, Stockholders' Equity (Deficit) o n August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $820,793.24, in exchange for an option to receive 4,100,000 Company Preferred Shares. The agreement settled, the deferred payment of his incremental base salary, his outstanding PTO as of July 31, 2022, and the remaining 50% of his approved bonus. In addition, Mr. Absher received the following additional payments during Fiscal 2021: (i) a one-time incentive payment of approximately $170,000 in connection with his relocation to Miami, Florida as part of the relocation of our principal executive offices, in addition to reimbursement of his expenses associated with his relocation; and (ii) a one-time bonus payment in the amount of $240,000 in recognition of his efforts on behalf of the Company. J. Stephen Holmes J. Stephen Holmes formerly served as a non-employee sales manager advisor to and significant shareholder of the Company. The Company incurred $750,000 in professional fees for services provided by Mr. Holmes during Fiscal 2021. On October 22, 2021, the Company severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company (See Note 11. Stockholders Equity (Deficit) and Note 16. C ontingencies.) Domonic J. Carney On May 24, 2022, Domonic J. Carney resigned as Chief Financial Officer and Treasurer of the Company, according to a Sabbatical Leave Agreement, effective immediately. The Company's Board of Directors accepted Mr. Carney's resignation and ratified the agreement the same day. As part of the agreement, Mr. Carney will receive back pay in the sum of $354,670.49, which includes unpaid past regular salary, unpaid PTO compensation, and unpaid past committed bonus compensation (collectively, "Back Pay"). The Company shall, according to the regularly scheduled semi-monthly pay dates of the 5th and 20th of each month (as adjusted to the nearest date preceding or following a weekend or holiday), make payments to Mr. Carney of the Back Pay in the gross amounts as are outlined in the agreed Payment Schedule, until the entire sum is paid in full. All applicable employment-related tax and withholding shall apply. On May 24, 2022, the Board of ShiftPixy appointed Manuel Rivera, 47, to the positions of Treasurer and Acting Chief Financial Officer of the Company. Since June 2021, Mr. Rivera has served as ShiftPixy's Vice President of Accounting. Mr. Rivera currently earns annual compensation as ShiftPixy's Vice President of Accounting of $194,606. There is currently no agreement between the Company and Mr. Rivera to adjust his current compensation. Related Persons to Scott Absher Mark Absher, the brother of Scott Absher, was previously employed as our Registered In-House Counsel, Director and Secretary. Mr. Absher resigned from his positions with the Company on February 6, 2019, and received compensation of $276,951 in Fiscal 2019. On November 18, 2021, Mr. Absher rejoined the Company as Deputy General Counsel – Special Projects, for an annual salary of 240,000 for Fiscal 2022. Based on his re-hire date, Mr. Absher did not receive any compensation from the Company in Fiscal 2021. David May, a member of our business development team, is the son-in-law of Mr. Absher. In addition to the relocation bonus noted above, Mr. May received compensation, including sales commissions, of approximately $149,000 for Fiscal 2022 and $125,000 in Fiscal 2021. Phil Eastvold, the Executive Producer of ShiftPixy Productions, Inc., is the son-in-law of Mr. Absher. In addition to the relocation bonus noted above, Mr. Eastvold received compensation of approximately $224,000 and $200,000 for Fiscal 2022 and Fiscal 2021, respectively. Jason Absher, a member of our business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher was hired on February 22, 2021, at an annual salary of $75,000, which was subsequently raised to $120,000, effective August 1, 2021. As of August 31, 2022, Mr. Jason Absher is still earning the same salary as of Fiscal Year 2021. Connie Absher, (the spouse of Scott Absher), Elizabeth Eastvold, (the daughter of Scott and Connie Absher and spouse of Mr. Eastvold), and Hannah Absher, (the daughter of Scott and Connie Absher), are also employed by the Company. These individuals, as a group, received aggregate compensation of 240,000 and $183,000 for Fiscal 2022 and Fiscal 2021. In addition, as noted above, Hannah Absher received a relocation bonus of approximately $18,000 during Fiscal 2021, in connection with her relocation. Neither Connie Absher nor Elizabeth Eastvold received any such relocation bonus.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Aug. 31, 2022
Income Tax Disclosure [Abstract]
Income taxes	Income Taxes Current income taxes are based upon the year’s income taxable for federal and state tax reporting purposes. Deferred income taxes (benefits) are provided for certain income and expenses, which are recognized in different periods for tax and financial reporting purposes. Deferred tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the period in which the differences are expected to affect taxable income. The Company’s deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses. These loss carryovers would be limited under the Internal Revenue Code should a significant change in ownership occur within a three-year period. Significant components of the net deferred tax assets as reflected on the consolidated balance sheets are as follows: August 31, 2022 2021 Deferred tax liabilities: Depreciation $ (587,000) $ (597,000) Note receivable — (1,088,000) Total deferred tax liabilities (587,000) (1,685,000) Deferred tax assets: Net operating loss carryforward 26,069,000 18,198,000 Business interest 2,942,000 2,998,000 Other accruals 896,000 458,000 Workers’ compensation accruals 1,734,000 2,061,000 Stock-based compensation 135,000 207,000 Deferred rent — 168,000 ASC 842 Lease liability 31,000 — Other 4,000 6,000 Total deferred tax assets 31,811,000 24,096,000 Valuation allowance (31,224,000) (22,411,000) Total net deferred tax assets $ 587,000 $ 1,685,000 Net deferred tax assets $ — $ — Income tax expense/(benefit) from continuing operations consists of the following: For the Year Ended August 31, 2022 2021 Current Federal $ — $ — State (38,000) 42,000 Total current (38,000) 42,000 Deferred Federal (6,177,000) (5,059,000) State (2,476,000) (2,807,000) Total deferred (8,653,000) (7,866,000) Change in valuation allowance $ 8,653,000 $ 7,866,000 Total Income Tax Expense (Benefit) $ (38,000) $ 42,000 The reconciliation of the statutory federal rate to the Company’s effective income tax rate is as follows: August 31, August 31, Federal statutory rate (21%) $ (9,124,000) $ (5,738,000) Inducement Loss 917,000 — Non-deductible penalties and other permanent differences 1,227,000 333,000 State and local income taxes, net of federal benefit (1,983,000) (1,607,000) Redetermination of prior year taxes 272,000 (812,000) Change in valuation allowance 8,653,000 7,866,000 Net income tax provision (Benefit) $ (38,000) $ 42,000 The Company’s continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of August 31, 2022, and 2021, the Company had no accrued interest and penalties related to uncertain tax positions. The deferred tax assets primarily comprise net operating loss carryforwards and other net temporary deductible differences such as stock-based compensation, deferred rent, depreciation and workers’ compensation accrual. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, the projected future taxable income and tax planning strategies in making this assessment. Based on management’s analysis, they concluded that it was more likely than not that the deferred tax asset would not be realized. Therefore, the Company established a full valuation allowance against the deferred tax assets. The change in the valuation allowance in 2022 and 2021 was approximately $8,653,000 and $7,866,000, respectively. As of August 31, 2022, and 2021, the Company had cumulative federal net operating loss ("NOL") carryforwards of approximately $93,597,000 and $64,652,000 respectively, which begin to expire in 2035 and state net operating loss carryforwards of approximately $100,780,000 and $68,034,000, respectively. The Company’s net operating losses may be limited by the provisions of IRC Section 382, for which the Company has not performed an analysis of the potential limitations. These limitations will be imposed when the Company attains taxable income against which the NOL will be utilized. As of August 31, 2022 and 2021, the company had NOLs of $66,755,000 and $37,809,000 which have an indefinite life but are limited to 80% of taxable income when used. As explained above, the Company has determined that it is more likely than not that the Company’s deferred tax assets related to NOL Carryforwards will not be utilized. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company' evaluated the impact of the CARES Act and determined that there was no material effect. The Company is subject to taxation in the U.S. The tax years for 2018 and forward are subject to examination by tax authorities. The Company is not currently under examination by any tax authority. Management has evaluated tax positions in accordance with FASB ASC 740, and has not identified any tax positions, other than those discussed above, that require disclosure. The Company does not expect a material change to this assessment over the 12 months following August 31, 2022. In August 2022 the United States enacted tax legislation through the Inflation Reduction Act (IRA). The IRA introduces a 15% corporate alternative minimum tax (CAMT) for corporations whose average annual adjusted financial statement income (AFSI) for any consecutive three-tax-year period ending after 31 December 2021 and preceding the tax year exceeds $1 billion. The CAMT is effective for tax years beginning after 31 December 2022. The CAMT is currently not applicable to the Company.

Commitments

Commitments	12 Months Ended
Commitments	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments Operating Lease Effective April 15, 2016, the Company entered into a non-cancelable five-year operating lease for its Irvine office facility. On July 25, 2017, the Company entered into a non-cancelable operating lease for expansion space at its Irvine offices with a termination date that coincides with the termination date of the prior lease and extended the terms of the original lease until June 2022. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $35,000. Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for 13,246 square feet of office space located in Miami, Florida to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $57,000. Effective October 1, 2020, the Company entered into a non-cancelable 64-month lease for 23,500 square feet of primarily industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $34,000. Effective June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $26,000. Effective June 21, 2021, the Company entered into a non-cancelable 77-month lease for premises consisting of approximately 13,418 square feet of office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The Company lease had possession date of August 1, 2022. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000. Effective May 2, 2022, the Company entered into a non-cancelable 60-month operating lease commencing on July 1, 2022, for office space in Irvine, California, which the Company anticipates using primarily to house its IT, operations personnel, and other elements of its workforce. The base rent is paid monthly and escalates annually according to a schedule outlined in the lease. The monthly rent expense under this lease is approximately $24,000. As an incentive, the landlord provided a rent abatement of 50% of the monthly rent for the first four months, with a right of recapture in the event of default. On August 31, 2022, the Company decided to formally abandon the leases for its offices in the Courvoisier Center, including a sublease on the second floor with Verifone. The determination was based on its inability to utilize the premises as they were under extensive construction by the landlord, resulting in a significant negative impact on the Company’s ability to conduct business and the health and well-being of the Company’s employees and guests. The Company formally notified the landlord of its intention to vacate the premises and has not been legally released from our primary obligations under the leases. The Company received a formal complaint from the landlord, and the matter is in litigation. The Company intends to vigorously defend the lawsuit and counterclaim for relocation costs. See Note 16, Contingencies . As a result of the abandonment, the Company evaluated the Right-Of-Use ("ROU") Assets for impairment as of August 31, 2022, and recorded an impairment charge of $3,866,802, within the impairment loss line item on the Consolidated Statements of Operations. Furthermore, the Company released the corresponding lease liability and evaluated the need for a loss contingency in accordance with ASC 450, recording a contingent liability of $3,761,352 in the accrued expenses of the Consolidated Balance sheet. The components of lease expense are as follows: August 31, 2022 August 31, Operating Lease Cost 1,362,902 $ 997,225 Future minimum lease and licensing payments under non-cancelable operating leases at August 31, 2022, are as follows: Minimum lease commitments 2023 973,517 2024 1,060,669 2025 1,095,396 2026 828,863 2027 648,387 Thereafter 319,125 Total minimum payments $ 4,925,957 Less: present value discount 631,033 Lease Liability $ 4,294,924 Weighted-average remaining lease term - operating leases (months) 70 Weighted-average discount rate 5.54 % The current portion of the operating lease liability is included within our accounts payable and other accrued liabilities Non-contributory 401(k) Plan The Company has a non-contributory 401(k) Plan (the “401(k) Plan”). The 401(k) Plan covers all non-union employees who are at least 21 years of age and have completed 3 months of service. There were no employer contributions to the 401(k) Plan during Fiscal 2022 and Fiscal 2021. SPAC Sponsorship On April 29, 2021, the Company announced its sponsorship, through a wholly-owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC, through its wholly-owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 20% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities). The registration statement and prospectus covering the IPO of one of these SPACs, IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. The Company also anticipates purchasing private placement warrants in each of the three other SPACs it is sponsoring, at a price of $1.00 per warrant, for an aggregate of $17,531,408 (or up to $18,656,408 if the over-allotment option of each SPAC is exercised in full), which includes the Company’s investment in Founder Shares and assumes that all four SPAC IPOs are consummated and the pricing terms of each other SPAC IPO is identical to the pricing of the IHC IPO. Each private placement warrant is exercisable to purchase one whole share of common stock in each SPAC at $11.50 per share. The private placement warrants of each SPAC will be worthless to the extent that they do not complete an initial business combination. The investment amounts set forth above do not include loans that the Company may extend to each SPAC in an amount not to exceed $500,000 individually (or $2 million in the aggregate), in its role as sponsor.

Contingencies

Contingencies	12 Months Ended
Contingencies	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow. Kadima Litigation The Company is in a dispute with its former software developer, Kadima Ventures (“Kadima”), over incomplete but paid for software development work. In May 2016, the Company entered into a contract with Kadima for the development and deployment of user features that were proposed by Kadima for an original build cost of $2.2 million to complete. This proposal was later revised upward to approximately $7.2 million to add certain features to the original proposal. As of the date of this Form 10-K, the Company has paid approximately $11 million to Kadima, but has never been provided access to the majority of the promised software. Kadima refused to continue development work, denied access to developed software, and refuses to surrender to the Company any software that it has developed unless the Company pays an additional $12.0 million above the $11.0 million already paid. In April 2019, Kadima filed a complaint against the Company in the Superior Court of the State of Arizona, Maricopa County, alleging claims for breach of contract, promissory estoppel and unjust enrichment, and seeking damages in excess of $11.0 million. The Company vigorously disputes and denies each of Kadima’s claims, including that it owes any sums to Kadima, and further believes that it is entitled, at a minimum, to a refund of a substantial portion of the sums that it has already paid, along with the release of the software modules currently being withheld. In June 2020, the Company engaged in a mediation with Kadima in an attempt to resolve the matter, which was unsuccessful. On July 14, 2020, the Company filed an answer to Kadima’s complaint, which denied Kadima’s claims and asserted counter-claims for breach of contract and fraud. T rial in the matter concluded on September 21, 2022. Post-trial briefs were due November 4, 2022, and responses thereto were due on November 18, 2022. As discussed in Note 17, Subsequent Events to the Consolidated Financial Statements, which is incorporated herein by reference, on November 23, 2022, an order was entered by the court, finding in favor of the Company and against Kadima in the amount of $5 million plus costs and fees. Splond Litigation On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. This lawsuit is in the initial stages, and the Company denies any liability. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award. Radaro Litigation On July 9, 2020, the Company was served with a complaint filed by one of its former software vendors, Radaro Inc., in the United States District Court for the Central District of California, alleging damages arising from claims sounding in breach of contract and fraud. By Order filed October 21, 2020, the Court dismissed plaintiff’s claims for fraud and for punitive damages, with leave to replead. The Company denied plaintiff’s claims and defended the lawsuit vigorously. A trial date was set for September 6, 2022, but the date was extended. As discussed in Note 17, Subsequent Events to the Consolidated Financial Statements, which is incorporated herein by reference, on October 31, 2022, the Company settled the claim with Radaro, the terms of which are confidential. Everest Litigation On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a retrospective rated policy, and seeks damages of approximately $600,000, which demand has since increased to approximately $1.6 million. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois. Everest subsequently filed a complaint against Gallagher Bassett in New Jersey. Discovery is underway in the cases, and the California Court has set a trial date in the Everest case of August 8, 2023, while no trial date has been set in either of the related Illinois or New Jersey cases, which are in preliminary stages. Sunz Litigation On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set. On June 21, 2022, the Court granted Plaintiff’s partial motion for summary judgment, holding that Defendant is liable under the contract, but further finding that the amount of damages, if any, to which Plaintiff is entitled should be determined at trial. We believe that partial summary judgment was improvidently granted, and therefore appealed the Court’s Order by filing a petition for writ of certiorari with the Court of Appeal, which appeal is now pending. Courvoisier Centre Litigation On August 24, 2022, the landlord of our headquarters offices, Courvoisier Centre, LLC, filed a complaint against the Company in the Eleventh Judicial Circuit Court (Miami-Dade County, Florida) alleging breach of the lease. We vacated the offices and ceased payments under the lease in July of 2022, after repeatedly complaining to the landlord regarding the impact of its extensive renovations of the campus and building in which our offices were situated, citing substantial impairments to the Company's ability to conduct business as well as concerns regarding the health and well-being of the Company’s employees and guests, and the Landlord’s inability and refusal to provide any adequate relief. On or about October 10, 2022, we filed our answer to the complaint and our counterclaim. Th e Company intends to vigorously defend the lawsuit and seek recovery for its costs of relocation. Certified Tire Litigation On June 29, 2020, the Company was served with a complaint filed by its former client, Certified Tire, in the Superior Court of the State of California, Orange County, naming the Company, two of its officers, and one of its former subsidiaries as defendants. The Complaint asserts multiple causes of action, all of which stem from the former client’s claim that the Company is obligated to reimburse it for sums it paid in settlement of a separate lawsuit brought by one of its employees pursuant to PAGA. This underlying lawsuit alleged that our former client was responsible for multiple violations of the California Labor Code. The Company and the officers named as defendants deny the former client’s allegations, and the Company is defending the lawsuit vigorously based primarily on our belief that the alleged violations that gave rise to the underlying lawsuit were the responsibility of Certified Tire and not the Company. Discovery is currently proceeding, and trial is scheduled to commence on January 9, 2023. The Company’s dispositive motion for summary judgment was denied by the court because of its determination that factual disputes exist. In Re John Stephen Holmes Bankruptcy Litigation As discussed in Note 17, Subsequent Events

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Aug. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated events that have occurred after the date of these consolidated balance sheets though the date that the consolidated financial statements were issued, and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with FASB ASC Topic 855, “Subsequent Events.” Effective August 31, 2022, the Company filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding shares of Common Stock. The reverse split became effective on Nasdaq September 1, 2022. On September 1, 2022, after our reverse stock split had taken effect, our CEO and Director, Scott Absher, converted 8,600,000 of his shares of Preferred Class A Stock to 8,600,000 shares of our common stock. On September 19, 2022, the Company received a letter from the staff of Nasdaq (the "Staff") notifying the Company that the Staff has determined that for the last 10 consecutive business days, from September 1 to September 16, 2022, the closing bid price of the Company’s common stock had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Listing Rule 5550(a)(2). On September 20, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The Offering closed on September 23, 2022. The gross proceeds to the Company from the Offering were approximately $5 million. In connection with the Purchase Agreement, the Company and the Purchaser entered into amendment No. 1 to warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01. A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a placement agent agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”)). The Placement Agent Warrants will be exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share. On October 31, 2022, the Company settled the claims filed against it by the plaintiff and one of the Company's former software vendors, Radaro, Inc. On November 8, 2022, the Chapter 7 trustee of the bankruptcy estate of John Stephen Holmes filed an action against the Company, asserting that the cancellation of Mr. Holmes' preferred options on October 22, 2021, violated the automatic stay applicable to Mr. Holmes' Chapter 7 proceedings. The matter is in the preliminary stages; the Company has not yet filed its response, but it plans to vigorously defend itself against the claim. On November 14, 2022, the court in the Sunz case granted the plaintiff's motion for partial summary judgment, holding that ShiftPixy waived claims for years 2 and 3 of the applicable policy based upon claims disputes for which it did not serve a "dispute notice" within a six-month period as set forth in the applicable contracts. On November 23, 2022, in the case filed against the Company by Kadima Ventures, an order was entered by the court, finding in favor of the Company and against Kadima in the amount of $5 million plus costs and fees. The order has not yet been reduced to a final judgment and will be subject to appeal. Industrial Human Capital At a special meeting of the stockholders of IHC (the SPAC sponsored by our subsidiary, ShiftPixy Investments, Inc.), held on October 14, 2022 (the “Meeting”), pursuant to a proxy statement, the stockholders by an affirmative vote of 73.70% of the 14,375,000 total shares of the Company’s common stock outstanding on the record date of September 6, 2022, approved IHC's proposed action to file an amended and restated certificate of incorporation (the “Amendment”) to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State. In connection with the Meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $114,949,913.76 (approximately $10.2165 per Public Share) will be removed from the Trust Account to pay such holders, subject to applicable law. Following the redemption, the Company’s remaining Public Shares outstanding would be 248,653, and the amount left in the Trust Account would be substantially below the $5,000,001 minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. On November 9, 2022, the Company filed a Certificate of Correction with the Secretary of State of Delaware, effectively withdrawing the previously filed Extension Amendment. A Certificate of Dissolution was filed on November 14, 2022.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Aug. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting, Policy	Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”).
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of ShiftPixy, Inc., and its wholly-owned subsidiaries. The Consolidated Financial Statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of our 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity ). All intercompany balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include: • Valuation related to Preferred stocks; • Liability for legal contingencies; • Useful lives of property and equipment; • Deferred income taxes and related valuation allowance; • Valuation of illiquid non-controlling interest in SPAC shares transferred; • Valuation of long-lived assets including long term notes receivable; and • Projected development of workers’ compensation claims.
Revenue from Contract with Customer	Revenue and Direct Cost Recognition On September 1, 2020, we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. Our revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and we did not have any significant changes in our business processes or systems. The Company’s revenues are primarily disaggregated in fees for providing staffing solutions and EAS/human capital management services. The Company enters into contracts with its clients for staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months but are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts our performance towards complete satisfaction of the performance obligation. Staffing Solutions The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes. EAS Solutions EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums. Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets, and were $2,105,000 and $2,741,000, as of August 31, 2022, and August 31, 2021, respectively. Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs. The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price. Disaggregation of Revenue The Company’s primary revenue streams include HCM and staffing services. The disaggregated Company’s revenues for Fiscal 2022 and Fiscal 2021 was as follows: Revenue (in millions): 2022 2021 HCM 1 $ 6.4 $ 8.2 Staffing 29.6 15.2 36.0 23.4 1 HCM revenue is presented net, $52.2 million gross less worksite employees payroll cost of $45.8 million for Fiscal 2022 and $63.8 million gross less worksite employees payroll cost of $55.6 million in Fiscal 2021.The Company is developing the ShiftPixy Labs, which is intended to launch multiple restaurants brands in the near future, however no revenue from this initiative has been earned as of the end of Fiscal 2022. For Fiscal 2022 and Fiscal 2021, the following geographical regions represented more than 10% of total revenues: Region: 2022 2021 California 52.1 % 70.3 % Washington 13.3 % 10.8 % Incremental Cost of Obtaining a Contract
Segment Reporting	Segment Reporting Prior to Fiscal 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting . The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis between Staffing and HCM services and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. See also Disaggregation of Revenue , above.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no such investments as of August 31, 2022, or August 31, 2021.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account As of August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IBC") or redemption of the public common shares of IHC.
Concentration of Credit Risk	Concentration of Credit RiskThe Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances.
Fixed Assets	Fixed Assets Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term.
Computer Software Development	Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software . Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three The Company determined that there were no material internal software development costs for Fiscal 2022 or Fiscal 2021. The Company also expenses internal costs related to minor upgrades and enhancements, as it is impractical to separate these costs from normal maintenance activities.
Lease Recognition	Lease Recognition In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the Statement of Operations. The Company adopted the standard on December 1, 2021, with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021. The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company. The standard had a material effect on the Company’s Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Consolidated Balance Sheet for the Company's office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities. Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.
Impairment and Disposal of Long-Lived Assets	Impairment and Disposal of Long-Lived Assets The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment
Workers' Compensation	Workers’ Compensation Everest Program Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 16, Contingencies, Everest Litigation , below. Sunz Program From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided through an arrangement with United Wisconsin Insurance Company and administered by the Sunz Insurance Company. Under this program, the Company has financial responsibility for the first $500,000 of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in its consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 16, Contingencies , Sunz Litigation , below. Current Program Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria. Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. Balance Sheet Items Related To Workers’ Compensation Under both the Everest and Sunz Programs, the Company utilized a third-party to estimate its loss development rate, which is based primarily upon the nature of WSE job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. As of August 31, 2022, the Company had no Deposit – workers’ compensation classified as a short-term or as a long-term asset related to any of these programs. The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.6 million and long term accrued workers’ compensation costs of $1.2 million. The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, part of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of August 31, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of August 31, 2022, the Company had $1.4 million of short term liabilities and $3.3 million of long term liabilities, with no short or long term assets. Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs which are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan. The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on our workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after August 31, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.
Debt Issuance Costs and Debt Discount	Debt Issuance Costs and Debt Discount Debt issuance costs and debt discounts are being amortized over the lives of the related financings on a basis that approximates the effective interest method. Costs and discounts are presented as a reduction of the related debt in the accompanying consolidated balance sheets. Portions attributable to notes converted into equity are accelerated to interest expense upon conversion.
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820, Fair Value Measurement , requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of August 31, 2022, and August 31, 2021, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at our estimate of expected collections value as described below and in Note 3, Discontinued Operations . The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are: • Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. • Level 2: Inputs to the valuation methodology include: ◦ Quoted prices for similar assets or liabilities in active markets; ◦ Quoted prices for identical or similar assets or liabilities in inactive markets; ◦ Inputs other than quoted prices that are observable for the asset or liability; ◦ Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and ◦ If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. • Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. As of August 31, 2022, and August 31, 2021, the Company valued the Note Receivable as discussed in Note 3, Discontinued Operations , below. Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying Consolidated Balance Sheet. The Company did not have other Level 1 or Level 2 assets or liabilities at August 31, 2022, or August 31, 2021. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of our sponsored SPACs being consummated. See also Note 5, Special Purpose Acquisition company (SPAC) and Note 6, Deferred Offering Costs – SPACS , below.
Advertising Costs	Advertising Costs The Company expenses all advertising as incurred.
Income Taxes	Income Taxes The Company accounts for income taxes pursuant to ASC 740, Income Taxes . Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.
Share-Based Compensation	Stock-Based Compensation As of August 31, 2022, and August 31, 2021, the Company had one stock-based compensation plan under which the Company may issue both share and stock option awards. The Company accounts for this plan under the recognition and measurement principles of ASC 718, Compensation- Stock Compensation , which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations at their fair values. Share grants are valued at the closing market price on the date of issuance, which approximates fair value. For option grants, the grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. Option grants are typically issued with vesting depending on a term of service. For all employee stock options granted, the Company recognizes expense over the employee’s requisite service period (generally the vesting period of the equity grant). The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since its initial public offering. Any changes in these highly subjective assumptions could materially impact stock-based compensation expense. Following the adoption of Accounting Standards Update (“ASU”) 2016-9, the Company elected to account for forfeitures as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.
Earnings (Loss) Per Share	Earnings (Loss) Per Share The Company utilizes FASB ASC 260, Earnings per Share . Basic earnings (loss) per share is computed by dividing earnings (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money share equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock is considered anti-dilutive and thus is excluded from the calculation. The number used for the weighted average number of shares of common stock outstanding for the earnings per share for the Fiscal 2022 and Fiscal 2021 was increased by 8,600,000 and 11,827,570, respectively. This increase reflects the inclusion of convertible preferred shares and common stock issuable upon full exercise of options to purchase a similar number of preferred shares and full conversion of those shares of preferred stock to shares of common stock. Securities used in, or that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, consist of the following: For the For the Options 11,753 17,761 Warrants 522,786 95,921 Total potentially dilutive shares 534,538 113,682 Preferred Options are excluded from the potentially dilutive shares in the table above since they are included in the weighted average outstanding share count for the basic earnings per share calculation. For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 11, Stock Based Compensation, below. The number of options and warrants have been presented retroactively for the 1 for 100 reverse stock split, which was effective September 1, 2022, before issuance of the financial statements.
Recent Accounting Standards	Recent Accounting Standards In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective. In August 2022, the FASB issued ASU 2020-6, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies the accounting for convertible debt instruments and convertible preferred stock by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. The update also requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. This update can be adopted on either a fully retrospective or a modified retrospective basis. The Company does not expect the adoption of ASU 2020-6 to have any material impact on its consolidated financial statements.
Variable Interest Entity	Variable Interest Entity The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are primarily formed to sponsor the related SPACs. The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities. During Fiscal 2022, our sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.7 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying Consolidated Balance Sheet at August 31, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC. Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, IHC could request an extension. If no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions. In connection with the IPO, we purchased, through investments, 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into our Consolidated Financial Statements.
Shares Subject to Possible Redemption	Shares Subject to Possible Redemption The Company accounts for its common stock holdings in its sponsored SPACs (which are consolidated in our Consolidated Financial Statements), that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, the Company classified the shares of common stock subject to possible redemption as temporary equity, outside of the shareholders’ equity section of the Company’s Consolidated Balance Sheet. Upon the November 9, 2022, filing of the Certificate of Correction with the Secretary of State of Delaware, effectively withdrawing the previously filed Extension Amendment and the November 14, 2022, filing of the Certificate of Dissolution, as described in Note 17, Subsequent Events, the Company reclassified these shares of common stock subject to possible redemption as a current liability of the Company's Consolidated Balance Sheet .
Accounts Receivable	Accounts receivable represent outstanding gross billings to clients, and are reported net of allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of specific accounts and by making a general provision, based on its past experiences, for other potentially uncollectible amounts.The Company makes an accrual at the end of each accounting period for the obligations associated with the earned but unpaid wages of its WSEs and for the accrued gross billings associated with such wages. These accruals are included in unbilled accounts receivable. The Company generally requires clients to pay invoices for service fees no later than 1 day prior to the applicable payroll date. As such, the Company generally does not require collateral.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Aug. 31, 2022
Accounting Policies [Abstract]
Disaggregation of Revenue	The disaggregated Company’s revenues for Fiscal 2022 and Fiscal 2021 was as follows: Revenue (in millions): 2022 2021 HCM 1 $ 6.4 $ 8.2 Staffing 29.6 15.2 36.0 23.4
Revenue from External Customers by Geographic Areas	For Fiscal 2022 and Fiscal 2021, the following geographical regions represented more than 10% of total revenues: Region: 2022 2021 California 52.1 % 70.3 % Washington 13.3 % 10.8 %
Schedule of Estimated Useful Lives of Property and Equipment	The estimated useful lives of property and equipment for purposes of computing depreciation are as follows: Equipment: 5 years Furnitures & Fixtures: 5 - 7 years Leasehold improvements Shorter of useful life or the remaining lease term, typically 5 years
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Securities used in, or that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, consist of the following: For the For the Options 11,753 17,761 Warrants 522,786 95,921 Total potentially dilutive shares 534,538 113,682

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
Discontinued Operations (Tables)	Aug. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule Of Disposal Groups Including Discontinued Operations, Reconciliation Of Gross Proceeds To Net Proceeds As Presented In Cash Flow Statement	The following is a reconciliation of the gross proceeds to the net Note Receivable from the Vensure Asset Sale as presented on the Company’s consolidated balance sheet for Fiscal 2022. Gross proceeds $ 19,166,000 Cash received at closing – asset sale (9,500,000) Cash received at closing – working capital (166,000) Gross note receivable $ 9,500,000 Less: Transaction reconciliation – estimated working capital adjustment (2,604,000) Adjusted note receivable 6,896,000 Less: Reserve for estimated potential claims (2,892,000) Less: Reserve on potential collectibility (4,004,000) Long-term note receivable $ —
Disposal Groups, Including Discontinued Operations	The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows: August 31, August 31, Deposits – workers’ compensation $ — $ 356,000 Total current assets — 356,000 Deposits – workers’ compensation — 883,000 Total assets $ — $ 1,239,000 Accrued workers’ compensation cost $ 1,362,000 $ 1,516,000 Total current liabilities 1,362,000 1,516,000 Accrued workers’ compensation cost 3,269,000 5,411,000 Total liabilities 4,631,000 6,927,000 Net liability $ (4,631,000) $ (5,688,000)
Schedule Of Disposal Groups Including Discontinued Operations Income Statement	Reported results for the discontinued operations by period were as follows: For the Year Ended August 31, 2022 August 31, 2021 Revenues $ — $ — Cost of revenue 590,000 2,509,000 Gross profit (590,000) (2,509,000) Operating expenses: Salaries, wages and payroll taxes — — Commissions — — Total operating expenses — — (Loss) income from discontinued operations $ (590,000) $ (2,509,000)
Schedule of Net Operating Loss Carryforwards Used to Offset Income from Discontinued Operations	The components of income tax expense for discontinued operations are as follows: For the Year Ended 2022 2021 Provision for income tax benefits Federal tax benefits $ (114,000) $ (500,000) State tax benefits (45,000) (129,000) Total tax benefits (159,000) (629,000) Valuation allowance on loss carryforwards 159,000 629,000 Provision for income tax expense from discontinued operations $ — $ —

Fixed Assets (Tables)

Fixed Assets (Tables)	12 Months Ended
Fixed Assets (Tables)	Aug. 31, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Fixed assets consisted of the following at August 31, 2022, and August 31, 2021: August 31, August 31, Equipment 2,700,000 2,386,000 Furniture & fixtures 614,000 599,000 Leasehold improvements 710,000 545,000 4,024,000 3,530,000 Accumulated depreciation & amortization (1,255,000) (746,000) Fixed assets, net $ 2,769,000 $ 2,784,000

Workers' Compensation (Tables)

Workers' Compensation (Tables)	12 Months Ended
Workers' Compensation (Tables)	Aug. 31, 2022
Compensation Related Costs [Abstract]
Summary of Workers' Compensation Deposit	The following table summarizes the workers’ compensation deposit from continuing operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Deposit at August 31, 2020 $ — 1,029,000 $ 1,029,000 Premiums paid — — — Paid in deposits — 446,000 446,000 Claim losses — (934,000) (934,000) Deposit refund — — — Workers’ Comp Deposit at August 31, 2021 $ — 541,000 $ 541,000 Paid in deposits — — — Claim losses — (541,000) (541,000) Workers’ Comp Deposit at August 31, 2022 — — — Less Current Amount — — — Long Term Balance at August 31, 2022 $ — — $ — The following table summarizes the workers’ compensation deposit from discontinued operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Deposit at August 31, 2020 $ — 3,611,000 $ 3,611,000 Premiums paid — — — Paid in deposits — 1,062,000 1,062,000 Claim losses — (3,434,000) (3,434,000) Deposit refund — — — Workers’ Comp Deposit at August 31, 2021 $ — 1,239,000 $ 1,239,000 Paid in deposits — — — Claim losses — (1,239,000) (1,239,000) Workers’ Comp Deposit at August 31, 2022 — — — Less Current Amount — — — Long Term Balance at August 31, 2022 $ — — $ —
Summary of Accrued Workers' Compensation Liability	The following table summarizes the accrued workers’ compensation liability from continuing operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Liability at August 31, 2020 $ 204,000 1,541,000 $ 1,745,000 Claim loss development 50,000 1,273,000 1,323,000 Paid in losses — (760,000) (760,000) Workers’ Comp Liability at August 31, 2021 $ 254,000 2,054,000 $ 2,308,000 Claim loss development 101,000 (130,000) (29,000) Paid in losses — (541,000) (541,000) Workers’ Comp Liability at August 31, 2022 355,000 1,383,000 1,738,000 Less Current Amount (135,000) (376,000) (511,000) Long Term Balance at August 31, 2022 $ 220,000 1,007,000 $ 1,227,000 The following table summarizes the accrued workers’ compensation liability from discontinued operations for Fiscal 2022 and Fiscal 2021: Everest SUNZ Total Workers’ Comp Liability at August 31, 2020 $ 717,000 5,405,000 $ 6,122,000 Claim loss development 103,000 2,639,000 2,742,000 Paid in losses — (3,583,000) (3,583,000) Workers’ Comp Liability at August 31, 2021 $ 820,000 4,461,000 $ 5,281,000 Claim loss development 130,000 459,000 589,000 Paid in losses — (1,239,000) (1,239,000) Workers’ Comp Liability at August 31, 2022 950,000 3,681,000 4,631,000 Less Current Amount (361,000) (1,001,000) (1,362,000) Long Term Balance at August 31, 2022 $ 589,000 2,680,000 $ 3,269,000

Accrued Payroll and Related L_2

Accrued Payroll and Related Liabilities (Tables)	12 Months Ended
Accrued Payroll and Related Liabilities (Tables)	Aug. 31, 2022
Accrued Payroll and Related Liabilities
Schedule of Accrued Liabilities	Accrued payroll liabilities consisted of the following at August 31, 2022, and August 31, 2021: August 31, August 31, Accrued Payroll $ 2,270,000 $ 2,438,000 Accrued Payroll Taxes 13,278,000 4,758,000 Corporate employee accrued paid time off 506,000 680,000 Accrued Payroll and related liabilities $ 16,054,000 $ 7,876,000

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
Stockholders' Equity (Deficit) (Tables)	Aug. 31, 2022
Equity [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights	The following table summarizes the changes in the Company’s issued and outstanding common stock and prefunded warrants from August 31, 2021, to August 31, 2022: Number Weighted Weighted Warrants outstanding, August 31, 2021 95,921 4.4 $ 384 Issued 573,109 7.6 83 (Cancelled) (25) 0 27,600 (Exercised) (146,220) 5.2 — Warrants outstanding, August 31, 2022 522,786 7.2 $ 78 Warrants exercisable, August 31, 2022 174,377 5.8 $ 161 The following tables summarize the Company’s issued and outstanding warrants outstanding as of August 31, 2022: Warrants Weighted average Exercise July 2022 Common Warrants (1) 348,408 7.9 $ 26.00 January 2022 Common Warrants 98,969 6.9 $ 26.00 September 2021 Common Warrants 25,235 6.7 $ 26.00 September 2021 Underwriter Warrants 3,762 6.7 $ 175.00 May 2021 Underwriter Warrants 2,474 3.7 267.00 October 2020 Common Warrants 23,000 3.1 330.00 October 2020 Underwriter Warrants 2,000 3.1 330.00 May 2020 Common Warrants 12,776 2.7 540.00 May 2020 Underwriter Warrants 1,111 2.7 540.00 March 2020 Exchange Warrants 4,237 3.1 1,017.00 Amended March 2019 Warrants 663 1.5 4,000.00 March 2019 Services Warrants 34 1.5 7,000.00 June 2018 Warrants 63 1.3 4,000.00 June 2018 Services Warrants 54 1.3 9,960.00 522,786 7.2 $ 71.00 (1)

Stock Based Compensation (Table

Stock Based Compensation (Tables)	12 Months Ended
Stock Based Compensation (Tables)	Aug. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Option, Activity	The following table summarizes the Company’s option grant, exercise and forfeiture activity from August 31, 2020, through August 31, 2022: Options Outstanding and Exercisable Number Weighted Weighted (In years) Balance, August 31, 2020 13,987 9.5 $ 818.00 Granted 8,400 8.5 261.00 Exercised — — — Forfeited (4,626) 5.9 272.00 Balance, August 31, 2021 17,761 8.9 653.00 Granted 1,400 9.8 105.00 Exercised — — — Forfeited (7,409) 8.4 454.00 Balance at August 31, 2022 11,753 8.1 $ 733.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable	Option vesting activity from August 31, 2020, through August 31, 2022, was as follows: Options Vested Number Weighted Weighted (In years) Balance, August 31, 2020 284 7.2 $ 11,510.00 Vested 2,816 8.8 $ 715.00 Exercised — — $ — Forfeited (8) 6.1 $ 6,717.00 Balance, August 31, 2021 3,092.57 8.6 $ 1,691.00 Vested 4,235 8.6 $ 488.00 Exercised — 0 $ — Forfeited (2,059) 8.1 $ 610.00 Balance at August 31, 2022 5,269 8.1 $ 1,146.00
Summary of Stock Options Outstanding	The following table summarizes information about stock options outstanding and vested at August 31, 2022: Options Outstanding Options Vested Exercise Prices Number Number Weighted Weighted Number Weighted Weighted (In years) (In years) $50.00-1,000.00 — 11,391 8.1 $ 425.00 4,920 8.1 $ 461.00 $1,001.00-$4,000.00 — 20 7.0 1,895.00 17 6.8 1,900.00 $4,001.00–$8,000.00 — 121 6.8 5,121.00 111 6.6 5,120.00 $8,001.00–$12,000.00 — 101 6.0 10,298.00 101 5.7 10,300.00 $12,001.00–$16,000.00 109 5.1 15,584.00 109 4.9 15,590.00 $16,001.00-$39,160.00 — 11 5.1 39,160.00 11 4.9 39,160.00 — 11,753 8.1 $ 733.00 5,269 8.1 $ 1,146.00

Income taxes (Tables)

Income taxes (Tables)	12 Months Ended
Income taxes (Tables)	Aug. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities	Significant components of the net deferred tax assets as reflected on the consolidated balance sheets are as follows: August 31, 2022 2021 Deferred tax liabilities: Depreciation $ (587,000) $ (597,000) Note receivable — (1,088,000) Total deferred tax liabilities (587,000) (1,685,000) Deferred tax assets: Net operating loss carryforward 26,069,000 18,198,000 Business interest 2,942,000 2,998,000 Other accruals 896,000 458,000 Workers’ compensation accruals 1,734,000 2,061,000 Stock-based compensation 135,000 207,000 Deferred rent — 168,000 ASC 842 Lease liability 31,000 — Other 4,000 6,000 Total deferred tax assets 31,811,000 24,096,000 Valuation allowance (31,224,000) (22,411,000) Total net deferred tax assets $ 587,000 $ 1,685,000 Net deferred tax assets $ — $ —
Schedule of Components of Income Tax Expense (Benefit)	Income tax expense/(benefit) from continuing operations consists of the following: For the Year Ended August 31, 2022 2021 Current Federal $ — $ — State (38,000) 42,000 Total current (38,000) 42,000 Deferred Federal (6,177,000) (5,059,000) State (2,476,000) (2,807,000) Total deferred (8,653,000) (7,866,000) Change in valuation allowance $ 8,653,000 $ 7,866,000 Total Income Tax Expense (Benefit) $ (38,000) $ 42,000
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the statutory federal rate to the Company’s effective income tax rate is as follows: August 31, August 31, Federal statutory rate (21%) $ (9,124,000) $ (5,738,000) Inducement Loss 917,000 — Non-deductible penalties and other permanent differences 1,227,000 333,000 State and local income taxes, net of federal benefit (1,983,000) (1,607,000) Redetermination of prior year taxes 272,000 (812,000) Change in valuation allowance 8,653,000 7,866,000 Net income tax provision (Benefit) $ (38,000) $ 42,000

Commitments (Tables)

Commitments (Tables)	12 Months Ended
Commitments (Tables)	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Lease, Cost	The components of lease expense are as follows: August 31, 2022 August 31, Operating Lease Cost 1,362,902 $ 997,225
Lessee, Operating Lease, Liability, Maturity	Future minimum lease and licensing payments under non-cancelable operating leases at August 31, 2022, are as follows: Minimum lease commitments 2023 973,517 2024 1,060,669 2025 1,095,396 2026 828,863 2027 648,387 Thereafter 319,125 Total minimum payments $ 4,925,957 Less: present value discount 631,033 Lease Liability $ 4,294,924 Weighted-average remaining lease term - operating leases (months) 70 Weighted-average discount rate 5.54 %

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)				12 Months Ended
	Sep. 01, 2022	Aug. 31, 2022 USD ($) plan $ / shares shares	Oct. 22, 2021 USD ($) $ / shares shares	Aug. 31, 2022 USD ($) plan $ / shares shares	Aug. 31, 2021 USD ($) $ / shares shares	Aug. 31, 2020 segment	Oct. 21, 2021 shares	Oct. 19, 2021 shares	Sep. 01, 2021 USD ($)
Concentration Risk [Line Items]
Contract with customer, term				12 months
Contract with customer, cancellation period				30 days
Unbilled accounts receivable		$ 2,105,000		$ 2,105,000	$ 2,741,000
Number of reportable segments \| segment						1
Cash in excess of amounts insured by the FDIC		614,900		$ 614,900
Property, plant and equipment, useful life				5 years
Research and development expense				$ 4,100,000	6,800,000
Lease Liability		4,294,924		4,294,924
Impaired asset expense				4,004,000	0
ROU asset impairment		3,866,802		3,851,000
Workers' compensation, claim responsibility per occurrence		500,000		500,000
Workers' compensation asset, current		0		0	155,000
Workers' compensation asset, noncurrent		0		0	386,000
Accrued workers’ compensation costs		567,000		567,000	663,000
Accrued workers’ compensation costs		1,227,000		1,227,000	1,646,000
Short term liabilities		1,400,000		1,400,000
Long term liabilities		3,300,000		3,300,000
Short term assets		0		0
Long term assets		$ 0		0
Advertising costs				$ 2,500,000	$ 2,600,000
Share based compensation arrangement by share based payment award number of stock-based compensation plans \| plan		1		1
Weighted average number of common shares outstanding for the earnings per share increased \| shares				8,600,000	11,827,570
Exercise price of warrants (in dollars per share) \| $ / shares		$ 78		$ 78	$ 384
Class of warrant or right, outstanding (in shares) \| shares		522,786		522,786	95,921
Common stock, shares, transferred (in shares) \| shares			15,000
Temporary equity, carrying amount, attributable to parent		$ 116,969,000	$ 116,725,000	$ 116,969,000	$ 0
Remeasurement of IHC temporary equity			13,000,000	13,675,000
Deferred offering costs – SPACs (See Note 5 and 6)		$ 0		0	48,261,000
SPAC related offering costs paid				$ 3,663,000	789,000
Subsequent Event
Concentration Risk [Line Items]
Stock split conversion ratio	0.01
Industrial Human Capital, Inc.
Concentration Risk [Line Items]
Remeasurement of IHC temporary equity			9,500,000
Deferred offering costs – SPACs (See Note 5 and 6)			$ 9,500,000		$ 9,800,000
Industrial Human Capital, Inc.
Concentration Risk [Line Items]
Variable interest entity, qualitative or quantitative information, ownership percentage				15%
Common stock, shares, owned (in shares) \| shares		2,110,000	2,110,000	2,110,000			2,125,000
SPAC related offering costs paid			$ 3,500,000	$ 3,500,000
IPO \| Industrial Human Capital, Inc.
Concentration Risk [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares				11,500,000
Proceeds from issuance initial public offering			115,000,000
Assets held-in-trust		$ 1,700,000	$ 1,725,000	$ 1,700,000
Price per share (in dollars per share) \| $ / shares			$ 10
Sale of stock, number of common shares issued per unit (in shares) \| shares			1					1
Sale of stock, number of warrants issued per unit (in shares) \| shares			1
Class of warrant or right, number of securities called by each warrant or right (in shares) \| shares			1					1
Exercise price of warrants (in dollars per share) \| $ / shares			$ 11.50
Business combination, initial business combination consummation period			12 months
Redeemable noncontrolling interest, equity, common, redemption percentage			100%
IPO \| Industrial Human Capital, Inc. \| Placement Warrants
Concentration Risk [Line Items]
Class of warrant or right, outstanding (in shares) \| shares			4,639,102
Sale of warrants (in dollars per share) \| $ / shares			$ 1
Aggregate purchase price			$ 4,639,102
Accounting Standards Update 2018-11
Concentration Risk [Line Items]
Lease Liability									$ 7,700,000
Minimum \| Software Development
Concentration Risk [Line Items]
Property, plant and equipment, useful life				3 years
Maximum \| Software Development
Concentration Risk [Line Items]
Property, plant and equipment, useful life				5 years
Two Clients \| Customer Concentration Risk \| Revenue from Contract with Customer Benchmark
Concentration Risk [Line Items]
Concentration of credit risk percent					10%
Five Clients \| Customer Concentration Risk \| Accounts Receivable
Concentration Risk [Line Items]
Concentration of credit risk percent				96%
Four Clients \| Customer Concentration Risk \| Accounts Receivable
Concentration Risk [Line Items]
Concentration of credit risk percent					94%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, excluding assessed tax	$ 36,002	$ 23,420
HCM Services
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, excluding assessed tax	6,400	8,200
Gross Billings	52,200	63,800
Worksite employee payroll cost	45,800	55,600
Staffing Services
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, excluding assessed tax	$ 29,600	$ 15,200

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue from External Customers by Geographical Areas (Details) - Revenue from Contract with Customer Benchmark - Geographic Concentration Risk	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
California
Concentration Risk [Line Items]
Concentration of credit risk percent	52.10%	70.30%
Washington
Concentration Risk [Line Items]
Concentration of credit risk percent	13.30%	10.80%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details)	12 Months Ended
	Aug. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Minimum \| Furniture & fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Maximum \| Furniture & fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Weighted average dilutive common shares (Details) - shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	534,538	113,682
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	11,753	17,761
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	522,786	95,921

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - USD ($) $ in Thousands		12 Months Ended
	Jan. 03, 2020	Aug. 31, 2022	Aug. 31, 2021	Mar. 12, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Working Capital Adjustments		$ 2,600		$ 10,700
Reserve for potential claims		2,900
Reserve on potential collectability		4,004
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]			Loss from discontinued operations, net of tax
Disposal group including discontinued operations, contingent consideration			$ 1,400
Reserved net operating loss carryforwards fully utilized to offset income from discontinuing operations		600	8,632
Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Lower net assets transferred at closing			100
Cash remitted to the Company's bank accounts by former clients			2,500
Overall business \| Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	88%
Working capital assets transferred	$ 1,500
Gross proceeds to be received	19,200	19,166
Net cash proceeds as presented in the statement of cash flows	9,700
Gross note receivable	$ 9,500	9,500
Period for payment of gross proceeds (in years)	4 years
Customer retention period (in years)	12 months
Disposal Group, Including Discontinued Operation, Working Capital Adjustments		2,604
Reserve for potential claims		$ 2,892
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax			15,600
Likely working capital adjustments			$ 2,600
Lower percentage of gross wages			90%
PEO business \| Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	100%

Discontinued Operations - Recon

Discontinued Operations - Reconciliation of Gross Proceeds to Net Proceeds From Sale Transaction (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Mar. 12, 2021	Jan. 03, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Less: Transaction reconciliation – estimated working capital adjustment	$ (2,600)		$ (10,700)
Less: Reserve for estimated potential claims	(2,900)
Less: Reserve on potential collectibility	(4,004)
Long-term note receivable	0	$ 4,004
Overall business \| Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross proceeds	19,166			$ 19,200
Cash received at closing – asset sale	(9,500)
Cash received at closing – working capital	(166)
Gross note receivable	9,500			$ 9,500
Less: Transaction reconciliation – estimated working capital adjustment	(2,604)
Adjusted note receivable	6,896
Less: Reserve for estimated potential claims	(2,892)
Long-term note receivable	$ 0

Discontinued Operations - Carry

Discontinued Operations - Carrying Amounts of Assets and Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total current assets	$ 0	$ 356
Total current liabilities	1,362	1,516
Disposal by sale \| Overall business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deposits – workers’ compensation	0	356
Total current assets	0	356
Deposits – workers’ compensation	0	883
Total assets	0	1,239
Accrued workers’ compensation cost	1,362	1,516
Total current liabilities	1,362	1,516
Accrued workers’ compensation cost	3,269	5,411
Total liabilities	4,631	6,927
Net liability	$ (4,631)	$ (5,688)

Discontinued Operations - Repor

Discontinued Operations - Reported Results for the Discontinued Operations (Details) - Disposal by sale - Overall business - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 0	$ 0
Cost of revenue	590	2,509
Gross profit	(590)	(2,509)
Operating expenses:
Salaries, wages and payroll taxes	0	0
Commissions	0	0
Total operating expenses	0	0
(Loss) income from discontinued operations	$ (590)	$ (2,509)

Discontinued Operations - Net O

Discontinued Operations - Net Operating Loss Carryforwards (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Provision for income tax benefits
Federal tax benefits	$ (114)	$ (500)
State tax benefits	(45)	(129)
Total tax benefits	(159)	(629)
Valuation allowance on loss carryforwards	159	629
Provision for income tax expense from discontinued operations	$ 0	$ 0

Going Concern - Narrative (Deta

Going Concern - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended			12 Months Ended
	Jul. 31, 2022	Jan. 31, 2022	Sep. 30, 2021	Aug. 31, 2022	Aug. 31, 2021
Going Concern [Line Items]
Cash				$ 618	$ 1,199
Working capital deficit				31,200
Net cash provided by (used in) operating activities				(17,520)	(21,512)
Retained earnings (accumulated deficit)				(192,725)	(149,338)
Proceeds from private placement offering, net of offering costs				4,183	11,062
Proceeds from warrant exercises	$ 1,300	$ 5,900
Proceeds from exercised warrants, net of offering costs	$ 1,200	$ 5,400		$ 6,573	$ 0
Private Placement
Going Concern [Line Items]
Proceeds from issuance of private placement			$ 12,000
Proceeds from private placement offering, net of offering costs			$ 11,100

Special Purpose Acquisition C_2

Special Purpose Acquisition Company ("SPAC") Sponsorship (Details)

12 Months Ended

Mar. 18, 2022 USD ($)

Oct. 22, 2021 USD ($) $ / shares shares

Aug. 31, 2022 USD ($) shares

Aug. 31, 2021 USD ($) shares

Oct. 15, 2022 shares

Oct. 14, 2022 USD ($) shares

Sep. 06, 2022 shares

Oct. 19, 2021 shares

Apr. 29, 2021 USD ($)

Apr. 29, 2021 sponsorship

Apr. 29, 2021

Apr. 29, 2021 company

Investments in and Advances to Affiliates [Line Items]

Number of special purpose acquisition company sponsorships

Other commitments, capital investment sought, per acquisition company

$ 150,000,000

Withdrawal from SPAC S-1 forms

$ 38,000,000

$ 37,978,000

Class of warrant or right, outstanding (in shares) | shares

522,786

95,921

Remeasurement of IHC temporary equity

$ 13,000,000

$ 13,675,000

SPAC related offering costs paid

3,663,000

$ 789,000

Investment income, interest

20,000

Other commitments, percentage of outstanding shares, per acquisition company

15%

Industrial Human Capital, Inc.

Investments in and Advances to Affiliates [Line Items]

Remeasurement of IHC temporary equity

9,500,000

Industrial Human Capital, Inc.

Investments in and Advances to Affiliates [Line Items]

Payment of deferred offering costs

300,000

SPAC related offering costs paid

$ 3,500,000

3,500,000

Firemark Global Capital, Inc.

Investments in and Advances to Affiliates [Line Items]

SPAC related offering costs paid

TechStackery, Inc.

Investments in and Advances to Affiliates [Line Items]

SPAC related offering costs paid

Vital Human Capital, Inc.

Investments in and Advances to Affiliates [Line Items]

SPAC related offering costs paid

IHC SPAC Sponsorship

Investments in and Advances to Affiliates [Line Items]

Other commitments, interest rate

1.50%

IHC | Subsequent Event

Investments in and Advances to Affiliates [Line Items]

Common stock, shares, outstanding (in shares) | shares

14,375,000

Assets held-in-trust, net tangible assets threshold

$ 5,000,001

IHC | Subsequent Event | Redeeming Shareholders

Investments in and Advances to Affiliates [Line Items]

Common stock, shares, outstanding (in shares) | shares

11,251,347

IHC | Subsequent Event | Public Shares

Investments in and Advances to Affiliates [Line Items]

Common stock, shares, outstanding (in shares) | shares

248,653

IPO | Industrial Human Capital, Inc.

Investments in and Advances to Affiliates [Line Items]

Sale of stock, number of common shares issued per unit (in shares) | shares

Class of warrant or right, number of securities called by each warrant or right (in shares) | shares

Proceeds from issuance initial public offering

$ 115,000,000

Assets held-in-trust

$ 1,725,000

$ 1,700,000

IPO | Industrial Human Capital, Inc. | Placement Warrants

Investments in and Advances to Affiliates [Line Items]

Class of warrant or right, outstanding (in shares) | shares

4,639,102

Sale of warrants (in dollars per share) | $ / shares

$ 1

Aggregate purchase price

$ 4,639,102

IPO | IHC

Investments in and Advances to Affiliates [Line Items]

Class of warrant or right, number of securities called by each warrant or right (in shares) | shares

Proceeds from issuance initial public offering

$ 115,000,000

IPO | IHC | Placement Warrants

Investments in and Advances to Affiliates [Line Items]

Class of warrant or right, outstanding (in shares) | shares

4,639,102

Sale of warrants (in dollars per share) | $ / shares

$ 1

Aggregate purchase price

$ 4,639,102

Deferred Offering Costs - SPA_2

Deferred Offering Costs - SPACs (Details)			3 Months Ended	12 Months Ended
Deferred Offering Costs - SPACs (Details)	Oct. 22, 2021 USD ($)	Apr. 22, 2021 USD ($) year $ / shares shares	May 31, 2022 USD ($)	Aug. 31, 2022 USD ($)	Aug. 31, 2021 USD ($)	Apr. 29, 2021 sponsorship	Apr. 29, 2021 company	Mar. 18, 2021 sponsorship
Noncontrolling Interest [Line Items]
Number of special purpose acquisition company sponsorships						4	4
Deferred offering costs – SPACs (See Note 5 and 6)				$ 0	$ 48,261,000
Accrued professional fees					789,000
Deferred offering costs, excluding fees				38,000,000	47,472,000
Remeasurement of IHC temporary equity	$ 13,000,000			13,675,000
Deferred offering costs, increase (decrease)				38,500,000
Other commitments, number of special purpose acquisition company sponsorships withdrawn from \| sponsorship								3
Expensed SPAC offering costs				$ 515,000	0
Firemark Global Capital, Inc.
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			$ 0
Vital Human Capital, Inc.
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			0
TechStackery, Inc.
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			$ 0
Measurement Input, Discount Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input \| year		0.488
Measurement Input, Consummation Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input \| year		0.20
Measurement Input, Special Acquisition Company Completion Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input \| year		0.20
Measurement Input, Concession Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input \| year		0.21
Industrial Human Capital, Inc.
Noncontrolling Interest [Line Items]
Deferred offering costs – SPACs (See Note 5 and 6)	9,500,000				$ 9,800,000
Remeasurement of IHC temporary equity	$ 9,500,000
Special Acquisition Company \| Third Party Representative \| ICH, TechStackery, Vital And Firemark
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares		10,000,000
Sale of stock, consideration received on transaction		$ 47,472,000
Price per share (in dollars per share) \| $ / shares		$ 4.7472
Sale of stock, stock and warrant price per share (in dollars per share) \| $ / shares		10
Sale of stock, price per warrant (in dollars per share) \| $ / shares		0.75
Sale of stock, unit price of share portion (in dollars per share) \| $ / shares		$ 9.25
Special Acquisition Company \| Third Party Representative \| IHC
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares		2,000,000
Special Acquisition Company \| Third Party Representative \| TechStackery, Inc.
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares		2,000,000
Special Acquisition Company \| Third Party Representative \| Vital Human Capital, Inc.
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares		2,000,000
Special Acquisition Company \| Third Party Representative \| Firemark Global Capital, Inc.
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) \| shares		4,000,000

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Thousands	12 Months Ended
Accounts Receivable (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Receivables [Abstract]
Accounts receivable, allowance for credit loss, writeoff	$ 0	$ 45

Fixed Assets (Details)

Fixed Assets (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 4,024	$ 3,530
Accumulated depreciation & amortization	(1,255)	(746)
Fixed assets, net	2,769	2,784
Equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,700	2,386
Furniture & fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	614	599
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 710	$ 545

Fixed Assets - Additional Infor

Fixed Assets - Additional Information (Details) - USD ($)	12 Months Ended
Fixed Assets - Additional Information (Details) - USD ($)	Aug. 31, 2022	Aug. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 509,000	$ 357,000
Capitalized software, useful life	5 years
Capitalized software, additions	$ 0	$ 0

Workers' Compensation - Narrati

Workers' Compensation - Narrative (Details) - program	12 Months Ended
Workers' Compensation - Narrative (Details) - program	Aug. 31, 2022	Aug. 31, 2021
Compensation Related Costs [Abstract]
Number of workers' compensation programs in effect	3	3

Workers' Compensation - Summary

Workers' Compensation - Summary of Worker's Compensation Deposit (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Workers' Compensation Deposit [Roll Forward]
Less Current Amount	$ 0	$ (155)
Deposits – workers’ compensation	0	386
Continuing operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	541	1,029
Premiums paid		0
Paid in deposits	0	446
Claim losses	(541)	(934)
Deposit refund		0
Workers' compensation deposit, ending balance	0	541
Less Current Amount	0
Deposits – workers’ compensation	0
Discontinued operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	1,239	3,611
Premiums paid		0
Paid in deposits	0	1,062
Claim losses	(1,239)	(3,434)
Deposit refund		0
Workers' compensation deposit, ending balance	0	1,239
Less Current Amount	0
Deposits – workers’ compensation	0
Everest Program \| Continuing operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	0	0
Premiums paid		0
Paid in deposits	0	0
Claim losses	0	0
Deposit refund		0
Workers' compensation deposit, ending balance	0	0
Less Current Amount	0
Deposits – workers’ compensation	0
Everest Program \| Discontinued operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	0	0
Premiums paid		0
Paid in deposits	0	0
Claim losses	0	0
Deposit refund		0
Workers' compensation deposit, ending balance	0	0
Less Current Amount	0
Deposits – workers’ compensation	0
SUNZ Program \| Continuing operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	541	1,029
Premiums paid		0
Paid in deposits	0	446
Claim losses	(541)	(934)
Deposit refund		0
Workers' compensation deposit, ending balance	0	541
Less Current Amount	0
Deposits – workers’ compensation	0
SUNZ Program \| Discontinued operations
Workers' Compensation Deposit [Roll Forward]
Workers' compensation deposit, beginning balance	1,239	3,611
Premiums paid		0
Paid in deposits	0	1,062
Claim losses	(1,239)	(3,434)
Deposit refund		0
Workers' compensation deposit, ending balance	0	$ 1,239
Less Current Amount	0
Deposits – workers’ compensation	$ 0

Workers' Compensation - Summa_2

Workers' Compensation - Summary of Accrued Workers' Compensation Liability (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Workers' Compensation Liability [Roll Forward]
Less Current Amount	$ (567)	$ (663)
Accrued workers’ compensation costs	1,227	1,646
Continuing operations
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	2,308	1,745
Claim loss development	(29)	1,323
Paid in losses	(541)	(760)
Workers' compensation liability, ending balance	1,738	2,308
Less Current Amount	(511)
Accrued workers’ compensation costs	1,227
Continuing operations \| Everest Program
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	254	204
Claim loss development	101	50
Paid in losses	0	0
Workers' compensation liability, ending balance	355	254
Less Current Amount	(135)
Accrued workers’ compensation costs	220
Continuing operations \| SUNZ Program
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	2,054	1,541
Claim loss development	(130)	1,273
Paid in losses	(541)	(760)
Workers' compensation liability, ending balance	1,383	2,054
Less Current Amount	(376)
Accrued workers’ compensation costs	1,007
Discontinued operations
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	5,281	6,122
Claim loss development	589	2,742
Paid in losses	(1,239)	(3,583)
Workers' compensation liability, ending balance	4,631	5,281
Less Current Amount	(1,362)
Accrued workers’ compensation costs	3,269
Discontinued operations \| Everest Program
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	820	717
Claim loss development	130	103
Paid in losses	0	0
Workers' compensation liability, ending balance	950	820
Less Current Amount	(361)
Accrued workers’ compensation costs	589
Discontinued operations \| SUNZ Program
Workers' Compensation Liability [Roll Forward]
Workers' compensation liability, beginning balance	4,461	5,405
Claim loss development	459	2,639
Paid in losses	(1,239)	(3,583)
Workers' compensation liability, ending balance	3,681	$ 4,461
Less Current Amount	(1,001)
Accrued workers’ compensation costs	$ 2,680

Accrued Payroll and Related L_3

Accrued Payroll and Related Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Accrued Payroll and Related Liabilities
Accrued Payroll	$ 2,270	$ 2,438
Accrued Payroll Taxes	13,278	4,758
Corporate employee accrued paid time off	506	680
Accrued Payroll and related liabilities	16,054	$ 7,876
Accrued interest and penalties on outstanding payroll taxes	1,100
Delinquent payroll taxes outstanding	$ 12,000

Stockholders' Equity (Deficit_2

Stockholders' Equity (Deficit) - Narrative (Details)

1 Months Ended

4 Months Ended

12 Months Ended

Aug. 12, 2022 USD ($) $ / shares shares

Jul. 25, 2022 USD ($) shares

Jul. 19, 2022 $ / shares shares

Jul. 18, 2022 $ / shares shares

Jul. 14, 2022 USD ($) multiple $ / shares shares

Jan. 28, 2022 shares

Jan. 26, 2022 USD ($) $ / shares shares

Oct. 22, 2021 shares

Sep. 03, 2021 shares

Aug. 13, 2021 $ / shares shares

May 17, 2021 USD ($) $ / shares shares

Oct. 14, 2020 USD ($) $ / shares shares

Oct. 08, 2020 $ / shares shares

Jun. 05, 2020 shares

Jun. 04, 2020 USD ($) shares

Sep. 30, 2021 USD ($) $ / shares shares

May 31, 2020 $ / shares

Nov. 30, 2020 shares

Aug. 31, 2022 USD ($) $ / shares shares

Aug. 31, 2021 USD ($) $ / shares shares

Aug. 31, 2020 USD ($) shares

Jun. 15, 2021

Jun. 04, 2021 $ / shares

May 31, 2021 $ / shares shares

Sep. 30, 2016 $ / shares shares

Class of Warrant or Right [Line Items]

Preferred stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Convertible preferred stock, shares issued upon conversion (in shares)

Compensation expense | $

$ 4,184,267

$ 1,593,579

Price per share (in dollars per share) | $ / shares

$ 3.62

Expected maturity period

3 years 9 months 7 days

10 years

Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate

0.47%

Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate

134%

Fair value exercise price (in dollars per share) | $ / shares

$ 0.0001

Stock options exercised (in shares)

Preferred stock issued | $

$ 3,723,000

$ 0

Number of shares cancelled (in shares)

7,409

4,626

Preferred stock, shares issued (in shares)

8,600,000

Options forfeited (in shares)

2,059

Preferred stock, shares outstanding (in shares)

8,600,000

Decrease in employee related liabilities | $

$ (8,179,000)

$ (2,124,000)

Shares of common stock issued (in shares)

50,000

49,485

Exercise price of warrants (in dollars per share) | $ / shares

$ 78

$ 384

Proceeds from issuance of common stock | $

$ 0

$ 10,701,000

SPAC related offering costs paid | $

$ 3,663,000

$ 789,000

Class of warrant or right, outstanding (in shares)

522,786

95,921

Common stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

(Exercised)

146,220

Adjustments to additional paid in capital, warrant issued | $

$ 6,861,000

Additional paid-in capital | $

151,731,000

$ 142,786,000

Deemed dividend from change in fair value from warrants modification | $

$ 15,703,000

$ 0

Preferred Stock Issued

Class of Warrant or Right [Line Items]

Stock options exercised (in shares)

294,490

Preferred stock, shares issued (in shares)

8,600,000

Shares of common stock issued (in shares)

16,600,000

12,500

Other Expense

Class of Warrant or Right [Line Items]

Compensation expense | $

$ 62,100,000

October 2020 Common Warrants

Class of Warrant or Right [Line Items]

Price per share (in dollars per share) | $ / shares

$ 330

Warrants outstanding (in shares)

2,000

Percentage on aggregate number of shares of common stock

Warrants and rights outstanding, requisite exercise period

6 months

Warrants term

5 years

Percentage of warrants exercisable price on offering price

110%

May 2021 Common Warrants

Class of Warrant or Right [Line Items]

Warrants term

5 years

Number of shares of common stock per warrant (in shares)

May 2021 Prefunded Warrants

Class of Warrant or Right [Line Items]

Number of shares of common stock per warrant (in shares)

Existing Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

49,485

Exercise price of warrants (in dollars per share) | $ / shares

$ 242.50

Common stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Fair value adjustment of warrants | $

$ 639,000

Adjustments to additional paid in capital, warrant issued | $

$ 130,000

Investor Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 26

$ 120

Class of warrant or right, outstanding (in shares)

50,000

(Exercised)

49,485

September 2021 Modified Warrants

Class of Warrant or Right [Line Items]

Fair value adjustment of warrants | $

488,700

January 2022 Modified Warrants

Class of Warrant or Right [Line Items]

Fair value adjustment of warrants | $

$ 599,700

January 2022 Common Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

98,969

Exercise price of warrants (in dollars per share) | $ / shares

$ 155

SPAC related offering costs paid | $

$ 461,000

Proceeds from issuance of warrants | $

5,900,000

Fair value adjustment of warrants | $

12,590,000

Adjustments to additional paid in capital, warrant issued | $

5,477,000

Additional paid-in capital | $

5,500,000

Deemed dividend from change in fair value from warrants modification | $

$ 7,731,000

New Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

348,408

Exercise price of warrants (in dollars per share) | $ / shares

$ 26

Warrants and rights outstanding, requisite exercise period

6 months

Warrants term

7 years

Adjustments to additional paid in capital, warrant issued | $

$ 1,200,000

Deemed dividend from change in fair value from warrants modification | $

7,972,500

Warrants and rights outstanding, new warrants as a percentage of existing warrants

200%

Warrants and rights outstanding, paid cost | $

100,000

July 2022 Common Warrants

Class of Warrant or Right [Line Items]

Fair value adjustment of warrants | $

$ 8,084,000

Chief Executive Officer | Scott W Absher

Class of Warrant or Right [Line Items]

Preferred stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Price per share (in dollars per share) | $ / shares

$ 0.2250

$ 0.2580

Expected maturity period

10 years

24 months

Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate

2.97%

3.06%

Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate

125.70%

125.664%

Fair value exercise price (in dollars per share) | $ / shares

$ 0.0001

Share-based compensation arrangement by share-based payment award, assets or earning power threshold for option exercise

50%

Convertible preferred stock, shares issuable upon conversion per preferred share

Options forfeited (in shares)

12,500,000

Decrease in employee related liabilities | $

$ 820,793.24

Shares issued for services rendered (in shares)

4,100,000

Common stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Chief Executive Officer | Preferred Stock Issued | Scott W Absher

Class of Warrant or Right [Line Items]

Preferred stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Stock options exercised (in shares)

12,500,000

Number of options available for grant to founder shareholders (in shares)

12,500,000

Preferred stock issued | $

$ 5,000

$ 1,250

Multiples of par value paid for preferred stock | multiple

Number option additionally available for grant to founder shareholders (in shares)

12,500,000

Conversion of stock, shares converted (in shares)

8,000,000

Preferred stock, shares outstanding (in shares)

4,500,000

Chief Executive Officer | Common Stock Issued | Scott W Absher

Class of Warrant or Right [Line Items]

Convertible preferred stock, shares issued upon conversion (in shares)

8,000,000

80,000

Common shares lock up period

6 months

Common stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

Founding Shareholder | Preferred Stock Issued | J. Stephen Holmes

Class of Warrant or Right [Line Items]

Number of shares cancelled (in shares)

11,790,000

Stock Option | Preferred Stock Issued

Class of Warrant or Right [Line Items]

Convertible preferred stock (in shares)

24,634,560

Stock Option | Chief Executive Officer | Scott W Absher

Class of Warrant or Right [Line Items]

Number of options available for grant to founder shareholders (in shares)

25,000,000

Convertible Preferred Stock | May 2020 Common Warrant

Class of Warrant or Right [Line Items]

Price per share (in dollars per share) | $ / shares

$ 2.52

Convertible Preferred Stock | Chief Executive Officer | Scott W Absher

Class of Warrant or Right [Line Items]

Price per share (in dollars per share) | $ / shares

$ 0.2025

$ 0.2322

Common Share Units

Class of Warrant or Right [Line Items]

Shares issued upon conversion (in shares)

294,490

Common shares lock up period

6 months

Common stock, freely tradeable shares, outstanding

294,490

Common Share Units | October 2020 Common Warrants

Class of Warrant or Right [Line Items]

Units issued (in shares)

3,000

Number of shares of common stock to be purchased accompanied by common warrant (in shares)

0.5

Common Share Units | Chief Executive Officer | Scott W Absher

Class of Warrant or Right [Line Items]

Shares issued upon conversion (in shares)

12,500,000

Common shares lock up period

24 months

Preferred Class A | Chief Executive Officer | Preferred Stock Issued | Scott W Absher

Class of Warrant or Right [Line Items]

Number of options available for grant to founder shareholders (in shares)

12,500,000

Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 71

Class of warrant or right, outstanding (in shares)

522,786

Warrants | October 2020 Common Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 330

Class of warrant or right, outstanding (in shares)

23,000

Warrants | September 2021 Underwriter Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 175

Class of warrant or right, outstanding (in shares)

3,762

Warrants | January 2022 Common Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 26

Class of warrant or right, outstanding (in shares)

98,969

Warrants | July 2022 Common Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 26

Class of warrant or right, outstanding (in shares)

348,408

Underwritten Public Offering | Common Stock Issued

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

40,000

Underwritten Public Offering | May 2020 Common Warrant

Class of Warrant or Right [Line Items]

SPAC related offering costs paid | $

$ 1,300,000

Underwritten Public Offering | Common Share Units

Class of Warrant or Right [Line Items]

Proceeds from issuance of common stock | $

$ 12,000,000

Underwritten Public Offering | Common Share Units | October 2020 Common Warrants

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

40,000

Price per share (in dollars per share) | $ / shares

$ 300

Exercise price of warrants (in dollars per share) | $ / shares

$ 330

Underwritten Public Offering | Warrants | October 2020 Common Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

23,000

Private Placement

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

28,500

Proceeds from issuance of common stock | $

$ 12,000,000

SPAC related offering costs paid | $

$ 900,000

Aggregate gross proceeds cash fee

Proceeds from issuance of private placement | $

$ 12,000,000

Private Placement | Common Stock Issued

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

28,500

49,485

Private Placement | May 2021 Common Warrants

Class of Warrant or Right [Line Items]

SPAC related offering costs paid | $

$ 940,000

Shares issued, price per share (in dollars per share) | $ / shares

$ 242.5

Private Placement | May 2021 Prefunded Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

49,485

Exercise price of warrants (in dollars per share) | $ / shares

$ 0.010

Class of warrant or right, outstanding (in shares)

26,285

Shares issued, price per share (in dollars per share) | $ / shares

$ 242.49

Private Placement | Placement Agent Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 266.75

Percentage on aggregate number of shares of common stock

Warrants and rights outstanding, requisite exercise period

6 months

Private Placement | Common Stock Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

28,500

Exercise price of warrants (in dollars per share) | $ / shares

$ 159.50

Warrants term

5 years

Number of shares of common stock per warrant (in shares)

Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares

$ 159.50

Private Placement | Pre-Funded Warrants

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

46,735

Exercise price of warrants (in dollars per share) | $ / shares

$ 0.010

Number of shares of common stock per warrant (in shares)

Class of warrant or right, outstanding (in shares)

46,735

Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares

$ 159.49

Private Placement | Offering

Class of Warrant or Right [Line Items]

Warrants to acquire shares of common stock (in shares)

75,235

Private Placement | Placement Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 175.45

Warrants and rights outstanding, requisite exercise period

6 months

Warrants term

4 years

Private Placement | September 2021 Modified Warrants

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

25,233

Private Placement | January 2022 Modified Warrants

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

98,969

Private Placement | Common Share Units | May 2021 Common Warrants

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

23,200

Private Placement | Warrants | May 2021 Common Warrants

Class of Warrant or Right [Line Items]

Shares of common stock issued (in shares)

26,285

Stockholders' Equity (Deficit_3

Stockholders' Equity (Deficit) - Summary of Information About Warrants Outstanding (Details) - $ / shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Number of shares
Number of shares outstanding, beginning balance (in shares)	95,921
Issued (in shares)	573,109
Exercised (in shares)	(146,220)
Cancelled (in shares)	(25)
Number of shares outstanding, ending balance (in shares)	522,786	95,921
Number of shares exercisable (in shares)	174,377
Weighted average remaining life (years)
Weighted average Life of Outstanding Warrants in years	7 years 2 months 12 days	4 years 4 months 24 days
Issued	7 years 7 months 6 days
(Exercised)	5 years 2 months 12 days
Weighted remaining life (years) exercisable	5 years 9 months 18 days
Weighted average exercise price
Weighted average exercise price (in dollars per share)	$ 78	$ 384
Issued (in dollars per share)	83
Cancelled (in dollars per share)	27,600
Weighted average exercise price exercisable (in dollars per share)	$ 161

Stockholders' Equity (Deficit_4

Stockholders' Equity (Deficit) - Summary of Warrants Outstanding (Details) - $ / shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Jan. 26, 2022	Sep. 30, 2021
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	522,786	95,921
Weighted average Life of Outstanding Warrants in years	7 years 2 months 12 days	4 years 4 months 24 days
Exercise price of warrants (in dollars per share)	$ 78	$ 384
Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	522,786
Weighted average Life of Outstanding Warrants in years	7 years 2 months 12 days
Exercise price of warrants (in dollars per share)	$ 71
July 2022 Common Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	348,408
Weighted average Life of Outstanding Warrants in years	7 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 26
January 2022 Common Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)			$ 155
January 2022 Common Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	98,969
Weighted average Life of Outstanding Warrants in years	6 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 26
September 2021 Common Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	25,235
Weighted average Life of Outstanding Warrants in years	6 years 8 months 12 days
Exercise price of warrants (in dollars per share)	$ 26
September 2021 Underwriter Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	3,762			3,762
Weighted average Life of Outstanding Warrants in years	6 years 8 months 12 days
Exercise price of warrants (in dollars per share)	$ 175
May 2021 Underwriter Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	2,474
Weighted average Life of Outstanding Warrants in years	3 years 8 months 12 days
Exercise price of warrants (in dollars per share)	$ 267
October 2020 Common Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	23,000
Weighted average Life of Outstanding Warrants in years	3 years 1 month 6 days
Exercise price of warrants (in dollars per share)	$ 330
October 2020 Underwriter Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	2,000
Weighted average Life of Outstanding Warrants in years	3 years 1 month 6 days
Exercise price of warrants (in dollars per share)	$ 330
May 2020 Common Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	12,776
Weighted average Life of Outstanding Warrants in years	2 years 8 months 12 days
Exercise price of warrants (in dollars per share)	$ 540
May 2020 Underwriter Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	1,111
Weighted average Life of Outstanding Warrants in years	2 years 8 months 12 days
Exercise price of warrants (in dollars per share)	$ 540
March 2020 Exchange Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	4,237
Weighted average Life of Outstanding Warrants in years	3 years 1 month 6 days
Exercise price of warrants (in dollars per share)	$ 1,017
Amended March 2019 Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	663
Weighted average Life of Outstanding Warrants in years	1 year 6 months
Exercise price of warrants (in dollars per share)	$ 4,000
March 2019 Services Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	34
Weighted average Life of Outstanding Warrants in years	1 year 6 months
Exercise price of warrants (in dollars per share)	$ 7,000
June 2018 Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	63
Weighted average Life of Outstanding Warrants in years	1 year 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 4,000
June 2018 Services Warrants \| Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	54
Weighted average Life of Outstanding Warrants in years	1 year 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 9,960

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details)		1 Months Ended	12 Months Ended
Stock Based Compensation - Narrative (Details)	Sep. 01, 2022	May 31, 2020	Aug. 31, 2022 USD ($) $ / shares	Aug. 31, 2021 USD ($) $ / shares	Jun. 04, 2021 $ / shares shares	Jul. 01, 2020 shares	Jun. 30, 2020 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock issuable (in shares) \| shares					3,000,000	3,000,000	250,000
Common stock, par or stated value per share (in dollars per share) \| $ / shares			$ 0.0001	$ 0.0001	$ 0.0001
Contractual life		3 years 9 months 7 days	10 years
Compensation expense			$ 4,184,267	$ 1,593,579
Stock-based compensation			$ 1,283,000	1,594,000
Weighted average vesting period for unrecognized deferred share-based compensation (in years)			3 years
Share-based payment arrangement, nonvested award, excluding option, cost not yet recognized, amount			$ 1,783,000
Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value			0
Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock split conversion ratio	0.01
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation			$ 225,000	$ 169,000
Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			4 years
Tranche one \| Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			25%
Vesting period			12 months
Tranche one \| Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			25%
Vesting period			1 year
Vesting ratably over the following three years \| Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			36 months

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Option Activity (Details) - $ / shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2020
Number of Options
Beginning balance (in shares)	17,761	13,987
Granted (in shares)	1,400	8,400
Exercised (in shares)	0	0
Forfeited (in shares)	(7,409)	(4,626)
Ending balance (in shares)	11,753	17,761	13,987
Options exercisable (in shares)	11,753	17,761	13,987
Weighted Average Remaining Contractual Life
Balance, outstanding	8 years 1 month 6 days	8 years 10 months 24 days	9 years 6 months
Balance, exercisable	8 years 1 month 6 days	8 years 10 months 24 days	9 years 6 months
Granted	9 years 9 months 18 days	8 years 6 months
Forfeited	8 years 4 months 24 days	5 years 10 months 24 days
Weighted Average Exercise Price
Outstanding (in dollars per share)	$ 733	$ 653	$ 818
Exercisable (in dollars per share)	653	818
Granted (in dollars per share)	105	261
Exercised (in dollars per share)	0	0
Forfeited (in dollars per share)	$ 454	$ 272

Stock Based Compensation - Sche

Stock Based Compensation - Schedule of Option Vesting Activity (Details) - $ / shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2020
Number of Options
Options vested, beginning balance (in shares)	3,092.57	284
Vested (in shares)	4,235	2,816
Exercised (in shares)	0	0
Forfeited (in shares)	(2,059)	(8)
Options vested, ending balance (in shares)	5,269	3,092.57	284
Weighted Remaining Contractual Life
Outstanding	8 years 1 month 6 days	8 years 7 months 6 days	7 years 2 months 12 days
Vested	8 years 7 months 6 days	8 years 9 months 18 days
Exercised	0 years	0 years
Forfeited	8 years 1 month 6 days	6 years 1 month 6 days
Weighted Average Exercise Price
Outstanding (in dollars per share)	$ 1,146	$ 1,691	$ 11,510
Vested (in dollars per share)	488	715
Exercised (in dollars per share)	0	0
Forfeited (in dollars per share)	$ 610	$ 6,717

Stock Based Compensation - Stoc

Stock Based Compensation - Stock options outstanding and vested (Details) - $ / shares	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2020
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	11,753
Number of Options Exercisable, Exercisable (in shares)	11,753
Weighted Average Remaining Contractual Life, Outstanding	8 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	8 years 1 month 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 733	$ 653	$ 818
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 733	$ 653	$ 818
Number of Options Vested (in shares)	5,269	3,092.57	284
Weighted Remaining Contractual Life	8 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 1,146	$ 1,691	$ 11,510
Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	11,391
Number of Options Exercisable, Exercisable (in shares)	11,391
Weighted Average Remaining Contractual Life, Outstanding	8 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	8 years 1 month 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 425
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 425
Number of Options Vested (in shares)	4,920
Weighted Remaining Contractual Life	8 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 461
Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	20
Number of Options Exercisable, Exercisable (in shares)	20
Weighted Average Remaining Contractual Life, Outstanding	7 years
Weighted Average Remaining Contractual Life, Exercisable	7 years
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 1,895
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 1,895
Number of Options Vested (in shares)	17
Weighted Remaining Contractual Life	6 years 9 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 1,900
Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	121
Number of Options Exercisable, Exercisable (in shares)	121
Weighted Average Remaining Contractual Life, Outstanding	6 years 9 months 18 days
Weighted Average Remaining Contractual Life, Exercisable	6 years 9 months 18 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5,121
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 5,121
Number of Options Vested (in shares)	111
Weighted Remaining Contractual Life	6 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 5,120
Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	101
Number of Options Exercisable, Exercisable (in shares)	101
Weighted Average Remaining Contractual Life, Outstanding	6 years
Weighted Average Remaining Contractual Life, Exercisable	6 years
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 10,298
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 10,298
Number of Options Vested (in shares)	101
Weighted Remaining Contractual Life	5 years 8 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 10,300
Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	109
Number of Options Exercisable, Exercisable (in shares)	109
Weighted Average Remaining Contractual Life, Outstanding	5 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	5 years 1 month 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 15,584
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 15,584
Number of Options Vested (in shares)	109
Weighted Remaining Contractual Life	4 years 10 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 15,590
Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	11
Number of Options Exercisable, Exercisable (in shares)	11
Weighted Average Remaining Contractual Life, Outstanding	5 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	5 years 1 month 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 39,160
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 39,160
Number of Options Vested (in shares)	11
Weighted Remaining Contractual Life	4 years 10 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 39,160
Minimum \| Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	50
Minimum \| Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	1,001
Minimum \| Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	4,001
Minimum \| Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	8,001
Minimum \| Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	12,001
Minimum \| Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	16,001
Maximum \| Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	1,000
Maximum \| Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	4,000
Maximum \| Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	8,000
Maximum \| Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	12,000
Maximum \| Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	16,000
Maximum \| Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	$ 39,160

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($)							1 Months Ended	12 Months Ended
	Aug. 12, 2022	May 24, 2022	Nov. 18, 2021	Oct. 22, 2021	Aug. 01, 2021	Feb. 02, 2021	Mar. 31, 2022	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2019
Related Party Transaction [Line Items]
Decrease in employee related liabilities								$ (8,179,000)	$ (2,124,000)
Professional fees								7,673,000	4,089,000
Affiliated Entity
Related Party Transaction [Line Items]
One-time incentive payment									650,000
Affiliated Entity \| Scott Absher
Related Party Transaction [Line Items]
One-time incentive payment									160,000
Affiliated Entity \| Amanda Murphy
Related Party Transaction [Line Items]
One-time incentive payment									80,000
Payments to employees								264,152	240,000
Salaried compensation				$ 500,000
Accrued salaries								157,000
Affiliated Entity \| David May
Related Party Transaction [Line Items]
One-time incentive payment									80,000
Compensation, including sales commissions								149,000	125,000
Affiliated Entity \| Phil Eastvold
Related Party Transaction [Line Items]
One-time incentive payment									88,000
Salaried compensation								224,000	200,000
Affiliated Entity \| Hannah Absher
Related Party Transaction [Line Items]
One-time incentive payment									18,000
Affiliated Entity \| Jared Holmes
Related Party Transaction [Line Items]
One-time incentive payment									18,000
Affiliated Entity \| J. Stephen Holmes
Related Party Transaction [Line Items]
Professional fees									750,000
Affiliated Entity \| Domonic J Carney
Related Party Transaction [Line Items]
Back pay, amount		$ 354,670.49
Affiliated Entity \| Mark Absher
Related Party Transaction [Line Items]
Payments to employees										$ 276,951
Salaried compensation			$ 240,000
Affiliated Entity \| Jason Absher
Related Party Transaction [Line Items]
Salaried compensation					$ 120,000	$ 75,000
Affiliated Entity \| Connie Absher, Elizabeth Eastvold, and Hannah Absher
Related Party Transaction [Line Items]
Payments to employees								240,000	183,000
Chief Executive Officer
Related Party Transaction [Line Items]
One-time incentive payment									170,000
Payments to employees								$ 764,673	750,000
Salaried compensation				1,000,000
Discretionary bonus				$ 500,000
Employee compensation, discretionary bonus, percent of tranche one				50%
Employee compensation, discretionary bonus, percent of tranche two				50%
Payments of discretionary bonus							$ 250,000
Decrease in employee related liabilities	$ 820,793.24
Shares issued for services rendered (in shares)	4,100,000
One-time bonus payment									$ 240,000
Chief Financial Officer
Related Party Transaction [Line Items]
Salaried compensation		$ 194,606

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Deferred tax liabilities:
Depreciation	$ (587)	$ (597)
Note receivable	0	(1,088)
Total deferred tax liabilities	(587)	(1,685)
Deferred tax assets:
Net operating loss carryforward	26,069	18,198
Business interest	2,942	2,998
Other accruals	896	458
Workers’ compensation accruals	1,734	2,061
Stock-based compensation	135	207
Deferred rent	0	168
ASC 842 Lease liability	31	0
Other	4	6
Total deferred tax assets	31,811	24,096
Valuation allowance	(31,224)	(22,411)
Total net deferred tax assets	587	1,685
Net deferred tax assets	$ 0	$ 0

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Current
Federal	$ 0	$ 0
State	(38)	42
Total current	(38)	42
Deferred
Federal	(6,177)	(5,059)
State	(2,476)	(2,807)
Total deferred	(8,653)	(7,866)
Change in valuation allowance	8,653	7,866
Total Income Tax Expense (Benefit)	$ (38)	$ 42

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Income Tax Disclosure [Abstract]
Federal statutory rate (21%)	$ (9,124)	$ (5,738)
Inducement Loss	917	0
Non-deductible penalties and other permanent differences	1,227	333
State and local income taxes, net of federal benefit	(1,983)	(1,607)
Redetermination of prior year taxes	272	(812)
Change in valuation allowance	8,653	7,866
Total Income Tax Expense (Benefit)	$ (38)	$ 42

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Aug. 31, 2021
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, valuation allowance	$ 8,653	$ 7,866
Net operating losses	66,755	37,809
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	93,597	64,652
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 100,780	$ 68,034

Commitments - Narrative (Detail

Commitments - Narrative (Details)

12 Months Ended

Aug. 31, 2022 USD ($) $ / shares shares

Oct. 31, 2021 USD ($)

Oct. 22, 2021 USD ($) sponsorship $ / shares shares

Aug. 31, 2022 USD ($) $ / shares shares

Aug. 31, 2021 USD ($) $ / shares shares

May 02, 2022

Oct. 19, 2021 shares

Jun. 21, 2021 ft²

Jun. 07, 2021 ft²

Apr. 29, 2021 USD ($)

Apr. 29, 2021 sponsorship

Apr. 29, 2021

Apr. 29, 2021 company

Oct. 01, 2020 ft²

Aug. 13, 2020 ft²

Apr. 15, 2016

Operating Leased Assets [Line Items]

ROU asset impairment

$ 3,866,802

$ 3,851,000

Loss contingency accrual

$ 3,761,352

Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]

Accounts payable and other accrued liabilities

Defined contribution plan, age requirement

21 years

Defined contribution plan, service requirement

3 months

Employer contribution plan

$ 0

Number of special purpose acquisition company sponsorships

Other commitments, percentage of outstanding shares, per acquisition company

15%

Warrants (in shares) | shares

522,786

95,921

Exercise price of warrants (in dollars per share) | $ / shares

$ 78

$ 384

Impairment of uncollectible loans

$ 400,000

SPAC 1

Operating Leased Assets [Line Items]

Other commitment

$ 25,000

SPAC 2

Operating Leased Assets [Line Items]

Other commitment

25,000

SPAC 3

Operating Leased Assets [Line Items]

Other commitment

25,000

SPAC 4

Operating Leased Assets [Line Items]

Other commitment

$ 25,000

Special Purpose Acquisition Companies

Operating Leased Assets [Line Items]

Other commitment

$ 2,000,000

Advances to special purpose acquisition companies

$ 820,000

Special Purpose Acquisition Company, Maximum Amount Per Individual Loan

Operating Leased Assets [Line Items]

Other commitment

500,000

Shiftpixy Founders

Operating Leased Assets [Line Items]

Other commitments, percentage of outstanding shares, per acquisition company

20%

Irvine Facility

Operating Leased Assets [Line Items]

Operating lease term

5 years

Operating lease, monthly expense

35,000

Miami Office Space Facility

Operating Leased Assets [Line Items]

Operating lease term

7 years

Operating lease, monthly expense

57,000

Area of real estate property | ft²

13,246

ShiftPixy Labs Facility

Operating Leased Assets [Line Items]

Operating lease term

64 months

Operating lease, monthly expense

34,000

Area of real estate property | ft²

23,500

Miami Verifone Facility

Operating Leased Assets [Line Items]

Operating lease, monthly expense

26,000

Area of real estate property | ft²

8,000

Sublease term

3 years

Sunrise Facility

Operating Leased Assets [Line Items]

Operating lease, monthly expense

27,000

Area of real estate property | ft²

13,418

Operating lease, lease not yet commenced, term

77 months

Second Irvine Facility

Operating Leased Assets [Line Items]

Operating lease, monthly expense

$ 24,000

Operating lease, lease not yet commenced, term

60 months

Operating lease, rent abatement percentage

50%

Operating lease, rent abatement period

4 months

IPO | IHC

Operating Leased Assets [Line Items]

Number of common shares per unit (in shares) | shares

Number of shares of common stock per warrant (in shares) | shares

Proceeds from issuance initial public offering

$ 115,000,000

IPO | ShiftPixy | Special Purpose Acquisition Company, Transactions Expected | IHC

Operating Leased Assets [Line Items]

Number of special purpose acquisition company sponsorships | sponsorship

IPO | Placement Warrants | IHC

Operating Leased Assets [Line Items]

Warrants (in shares) | shares

4,639,102

Aggregate purchase price

$ 4,639,102

Sale of warrants (in dollars per share) | $ / shares

$ 1

Exercise price of warrants (in dollars per share) | $ / shares

$ 11.50

IPO | Placement Warrants | ShiftPixy | Special Purpose Acquisition Company, Transactions Expected | IHC

Operating Leased Assets [Line Items]

Aggregate purchase price

$ 17,531,408

Sale of warrants (in dollars per share) | $ / shares

$ 1

Overallotment | Placement Warrants | ShiftPixy | Special Purpose Acquisition Company, Transactions Expected | IHC

Operating Leased Assets [Line Items]

Aggregate purchase price

$ 18,656,408

Commitments - Lease, Cost (Deta

Commitments - Lease, Cost (Details) - USD ($)	12 Months Ended
Commitments - Lease, Cost (Details) - USD ($)	Aug. 31, 2022	Aug. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Operating Lease Cost	$ 1,362,902	$ 997,225

Commitments - Lessee, Operating

Commitments - Lessee, Operating Lease, Liability, Maturity (Details)	Aug. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2023	$ 973,517
2024	1,060,669
2025	1,095,396
2026	828,863
2027	648,387
Thereafter	319,125
Total minimum payments	4,925,957
Less: present value discount	631,033
Lease Liability	$ 4,294,924
Weighted-average remaining lease term - operating leases (months)	70 months
Weighted-average discount rate	5.54%

Contingencies (Details)

Contingencies (Details) - USD ($) $ in Millions				1 Months Ended		12 Months Ended
Contingencies (Details) - USD ($) $ in Millions	Nov. 23, 2022	Mar. 19, 2021	Dec. 18, 2020	Apr. 30, 2019	May 31, 2016	Aug. 31, 2022
Kadima Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Litigation settlement, amount awarded from other party	$ 5
Everest Litigaton
Loss Contingencies [Line Items]
Loss contingency, damages sought, value			$ 0.6			$ 1.6
Sunz Litigation
Loss Contingencies [Line Items]
Loss contingency, damages sought, value		$ 10
Software Development \| Kadima Litigation
Loss Contingencies [Line Items]
Software development cost					$ 2.2
Revised development costs					7.2
Software modules cost						$ 11
Additional software modules cost demanded					$ 12
Loss contingency, damages sought, value				$ 11

Subsequent Events (Details)

1 Months Ended

12 Months Ended

Nov. 23, 2022 USD ($)

Oct. 14, 2022 USD ($) $ / shares shares

Sep. 20, 2022 USD ($) warrant $ / shares shares

Sep. 01, 2022 shares

Jul. 18, 2022 shares

Jan. 28, 2022 shares

Jan. 26, 2022 shares

Sep. 03, 2021 shares

Sep. 30, 2021 USD ($) $ / shares shares

Aug. 31, 2022 $ / shares shares

Aug. 31, 2021 $ / shares shares

Oct. 15, 2022 shares

Sep. 06, 2022 shares

May 17, 2021

Subsequent Event [Line Items]

Exercise price of warrants (in dollars per share) | $ / shares

$ 78

$ 384

Stock issued during period, shares, new issues (in shares)

50,000

49,485

Preferred Stock

Subsequent Event [Line Items]

Stock issued during period, shares, new issues (in shares)

16,600,000

12,500

Private Placement

Subsequent Event [Line Items]

Proceeds from issuance of private placement | $

$ 12,000,000

Stock issued during period, shares, new issues (in shares)

28,500

Aggregate gross proceeds cash fee

Private Placement | Common Stock

Subsequent Event [Line Items]

Stock issued during period, shares, new issues (in shares)

28,500

49,485

Common Stock Warrants | Private Placement

Subsequent Event [Line Items]

Warrants to acquire shares of common stock (in shares)

28,500

Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares

$ 159.50

Warrants term

5 years

Exercise price of warrants (in dollars per share) | $ / shares

$ 159.50

September 2021 Modified Warrants | Private Placement

Subsequent Event [Line Items]

Stock issued during period, shares, new issues (in shares)

25,233

January 2022 Modified Warrants | Private Placement

Subsequent Event [Line Items]

Stock issued during period, shares, new issues (in shares)

98,969

Subsequent Event

Subsequent Event [Line Items]

Stock split conversion ratio

0.01

Subsequent Event | Kadima Litigation

Subsequent Event [Line Items]

Litigation settlement, amount awarded from other party | $

$ 5,000,000

Subsequent Event | Preferred Stock

Subsequent Event [Line Items]

Conversion of stock, shares converted (in shares)

8,600,000

Subsequent Event | Common Stock

Subsequent Event [Line Items]

Shares issued upon conversion (in shares)

8,600,000

Subsequent Event | IHC

Subsequent Event [Line Items]

Stockholder voting percentage

73.70%

Common stock, shares, outstanding (in shares)

14,375,000

Assets held-in-trust, payment to redeeming shareholders | $

$ 114,949,913.76

Assets held-in-trust, payment to redeeming shareholders per share (in dollars per share) | $ / shares

$ 10.2165

Assets held-in-trust, net tangible assets threshold | $

$ 5,000,001

Subsequent Event | IHC | Redeeming Shareholders

Subsequent Event [Line Items]

Common stock, shares, outstanding (in shares)

11,251,347

Subsequent Event | Private Placement

Subsequent Event [Line Items]

Sale of stock, number of shares and warrants issued in transaction (in shares)

416,667

Exercise price of warrants (in dollars per share) | $ / shares

$ 0.01

Subsequent Event | Overallotment

Subsequent Event [Line Items]

Warrants to acquire shares of common stock (in shares)

20,833

Warrants term

4 years

Exercise price of warrants (in dollars per share) | $ / shares

$ 13.20

Aggregate gross proceeds cash fee

Sale of stock, common stock shares as a percent of offering

Subsequent Event | Common Stock Warrants | Private Placement

Subsequent Event [Line Items]

Warrants to acquire shares of common stock (in shares)

833,334

Sale of stock, number of warrants accompanying each common share | warrant

Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares

$ 12

Warrants term

7 years

Exercise price of warrants (in dollars per share) | $ / shares

$ 12

Proceeds from issuance of private placement | $

$ 5,000,000

Subsequent Event | Public Shares | IHC

Subsequent Event [Line Items]

Common stock, shares, outstanding (in shares)

248,653